( (TITLE (NP (NP (NN Production) (CC and) (NN characterization)) (PP (IN of) (NP (NP (JJ murine) (NNS models)) (PP (IN of) (NP (ADJP (JJ classic) (CC and) (JJ intermediate)) (NML (NN maple) (NN syrup)) (NN urine) (NN disease))))))) )
( (HEADING (NP (NN Abstract))) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NP (NML (NN Maple) (NN Syrup)) (NN Urine) (NN Disease)) (-LRB- -LRB-) (NP (NN MSUD))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (NP (NP (DT an) (JJ inborn) (NN error)) (PP (IN of) (NP (NN metabolism)))) (VP (VBN caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT a) (NN deficiency)) (PP (IN of) (NP (NML (VBN branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase)))))))) (. .)) )
( (S (NP-SBJ (NN MSUD)) (VP (VBZ has) (NP (JJ several) (JJ clinical) (NNS phenotypes)) (PP (VBG depending) (PP (IN on) (NP (NP (DT the) (NN degree)) (PP (IN of) (NP (NN enzyme) (NN deficiency))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Current) (NNS treatments)) (VP (VP (VBP are) (RB not) (ADJP-PRD (JJ satisfactory))) (CC and) (VP (VBP require) (NP (JJ new) (NNS approaches)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB combat) (NP (DT this) (NN disease))))))) (. .)) )
( (S (NP-SBJ (NP (DT A) (JJ major) (NN hurdle)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG developing) (NP (JJ new) (NNS treatments)))))) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT the) (NN lack)) (PP (IN of) (NP (DT a) (JJ suitable) (NN animal) (NN model)))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB create) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (JJ classic) (NN MSUD))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (NP (NN gene) (NN targeting)) (CC and) (NP (NML (JJ embryonic) (NN stem) (NN cell)) (NNS technologies))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (DT a) (NN mouse) (NN line)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD lacked) (NP (NP (DT a) (JJ functional) (NN E2) (NN subunit) (NN gene)) (PP (IN of) (NP (NML (VBN branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase)))))))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB create) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (JJ intermediate) (NN MSUD))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (JJ transgenic) (NN technology)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB express) (NP (NP (DT a) (JJ human) (NN E2) (NN cDNA)) (PP (IN on) (NP (DT the) (NN knockout) (NN background)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Mice)) (PP (IN of) (NP (DT both) (NNS models)))) (VP (VBD were) (VP (VBN characterized) (NP-1 (-NONE- *)) (PP (IN at) (NP (DT the) (UCP (ADJP (JJ molecular)) (, ,) (ADJP (JJ biochemical)) (, ,) (CC and) (NML (JJ whole) (NN animal))) (NNS levels))))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (S (PP-MNR (IN By) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG disrupting) (NP (NP (DT the) (NN E2) (NN subunit) (NN gene)) (PP (IN of) (NP (NML (VBN branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD created) (NP (NP (DT a) (NML (NN gene) (NN knockout)) (NN mouse) (NN model)) (PP (IN of) (NP (JJ classic) (NN MSUD))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ homozygous) (NN knockout) (NNS mice)) (VP (VP (VBD lacked) (NP (NP (NML (NML (VBN branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase)) (NN activity)) (, ,) (NP (NN E2) (NN immunoreactivity)))) (, ,) (CC and) (VP (VBD had) (NP (NP (DT a) (QP (CD 3) (HYPH -) (JJ fold)) (NN increase)) (PP (IN in) (NP (VBG circulating) (NML (VBN branched) (HYPH -) (NN chain)) (NN amino) (NNS acids)))))) (. .)) )
( (S (NP-SBJ (DT These) (JJ metabolic) (NNS derangements)) (VP (VBD resulted) (PP (IN in) (NP (JJ neonatal) (NN lethality)))) (. .)) )
( (S (NP-SBJ (NP (JJ Transgenic) (NN expression)) (PP (IN of) (NP (DT a) (JJ human) (NN E2) (NN cDNA))) (PP-LOC (IN in) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (DT the) (NN E2) (NN knockout) (NNS animals)))))) (VP (VBD produced) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ intermediate) (NN MSUD))))) (. .)) )
( (S (NP-SBJ-1 (NML (NML (VBN Branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase)) (NN activity)) (VP (VP (VP (VBD was) (NP-PRD (NP (QP (CD 5) (SYM –) (CD 6)) (NN %)) (PP (IN of) (ADJP (JJ normal))))) (CC and) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB allow) (NP (NN survival)))))))) (, ,) (CC but) (VP (VBD was) (ADJP-PRD (JJ insufficient) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB normalize) (VP (VBG circulating) (NP (NP (NML (NML (VBN branched) (HYPH -) (NN chain)) (NN amino) (NNS acids)) (NNS levels)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ intermediate)) (PP (IN between) (NP (NP (NN wildtype)) (CC and) (NP (DT the) (JJ classic) (NN MSUD) (NN mouse) (NN model))))))))))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (NP-SBJ (DT These) (NNS mice)) (VP (VBP represent) (NP (NP (JJ important) (NN animal) (NNS models)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB closely)) (VP (VBP approximate) (NP (NP (DT the) (NN phenotype)) (PP (IN of) (NP (NP (NNS humans)) (PP (IN with) (NP (NP (DT the) (ADJP (JJ classic) (CC and) (JJ intermediate)) (NNS forms)) (PP (IN of) (NP (NN MSUD))))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS animals)) (VP (VBP provide) (NP (NP (NP (JJ useful) (NNS models)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB further)) (VP (VB characterize) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN MSUD))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS models)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP (NP (JJ novel) (JJ therapeutic) (NNS strategies)) (, ,) (PP (JJ such) (IN as) (NP (NP (UCP (NN gene) (CC and) (JJ cellular)) (NNS therapies)) (, ,) (SBAR (WHNP-4 (-NONE- *0*)) (S (NP-SBJ-4 (-NONE- *PRO*)) (VP (TO to) (VP (VB treat) (NP (DT this) (VBG devastating) (JJ metabolic) (NN disease)))))))))))))))) (. .)) )
( (HEADING (NP (NN Background))) )
( (S (NP-SBJ (NP (NML (NN Maple) (NN Syrup)) (NN Urine) (NN Disease)) (-LRB- -LRB-) (NP (NN MSUD))) (-RRB- -RRB-) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ genetic) (NN disorder)) (VP (VBN caused) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (NN deficiency)) (PP (IN of) (NP (NP (NML (VBN branched) (HYPH -) (NN chain)) (NML (NN keto) (NN acid)) (NN dehydrogenase)) (-LRB- -LRB-) (NP (NN BCKDH))))) (-RRB- -RRB-) (, ,) (NP (NP (DT a) (JJ mitochondrial) (NN multienzyme) (NN complex)) (ADJP (JJ responsible) (PP (IN for) (NP (NP (DT the) (JJ oxidative) (NN decarboxylation)) (PP (IN of) (NP (NP (NML (VBN branched) (HYPH -) (NN chain)) (NN keto) (NNS acids)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (NP (NML (VBN branched) (HYPH -) (NN chain)) (NN amino) (NNS acids)) (-LRB- -LRB-) (NP (NN BCAA))) (-RRB- -RRB-) (, ,) (NP (NN leucine)) (, ,) (NP (NN isoleucine)) (CC and) (NP (NN valine))))))))))))))) (PRN (-LRB- -LRB-) (S-IMP (PP (IN for) (NP (NN review))) (, ,) (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (: :) (-LRB- [) (NP (CD 1)))) (-RRB- ]) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (NNS Patients)) (PP (IN with) (NP (NN MSUD)))) (, ,) (PP (VBG depending) (PP (IN on) (NP (DT the) (NN mutation)))) (, ,) (VP (VBP show) (NP (NP (JJ variable) (NNS degrees)) (PP (IN of) (NP (NP (NN enzyme) (NN deficiency)) (VP (VBG leading) (PP (IN to) (NP (JJ several) (JJ different) (JJ clinical) (NNS phenotypes))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (QP (RB Approximately) (CD 75)) (NN %)) (PP (IN of) (NP (NN MSUD) (NNS patients)))) (VP (VBP have) (NP (NP (DT the) (JJ classic) (NN form)) (PP (IN of) (NP (DT the) (NN disease))) (PP (IN with) (NP (NP (NN BCKDH) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (QP (CD 0) (SYM –) (CD 2)) (NN %)) (PP (IN of) (NP (JJ normal)))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (DT These) (NNS patients)) (VP (VBP show) (NP (NP (ADJP (RB markedly) (VBN elevated)) (NNS levels)) (PP (IN of) (NP (NN BCAA)))) (PP-LOC (IN in) (NP (NP (NN blood)) (CC and) (NP (JJ other) (NN body) (NNS fluids)))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (PP (IN Besides) (NP (DT the) (JJ classic) (NN form))) (, ,) (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (JJ other) (NNS variants)) (PP (IN of) (NP (DT the) (NN disease))))) (. .)) )
( (S (NP-SBJ (NP (NNS Patients)) (PP (IN with) (NP (NP (DT the) (JJ intermediate) (NN form)) (PP (IN of) (NP (DT the) (NN disease)))))) (VP (VBP show) (NP (NP (NN BCKDH) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (QP (CD 3) (SYM –) (CD 30)) (NN %)) (PP (IN of) (NP (JJ normal))))))))) (. .)) )
( (S (S (PP-LOC (IN In) (NP (JJ such) (NNS patients))) (NP-SBJ-1 (NP (DT the) (NN onset)) (PP (IN of) (NP (DT the) (NN disease)))) (VP (VBZ is) (VP (VBN delayed) (NP-1 (-NONE- *))))) (, ,) (CC but) (S (NP-SBJ (EX there)) (VP (VBP are) (NP-PRD (NP (ADJP (RB persistently) (VBN elevated)) (NNS levels)) (PP (IN of) (NP (NN BCAA)))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (NNS Patients)) (PP (IN with) (NP (NP (DT the) (JJ intermittent) (NN form)) (PP (IN of) (NP (NN MSUD)))))) (VP (VBP show) (NP (NN BCKDH) (NN activity)) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (QP (CD 5) (SYM –) (CD 20)) (NN %))))))) (CC and) (S (PP-TMP (IN during) (NP (DT the) (JJ asymptomatic) (NN phase))) (NP-SBJ (DT the) (NN blood) (NN BCAA) (NNS levels)) (VP (VBP are) (ADJP-PRD (JJ normal)) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (JJ overall) (NN incidence)) (PP (IN of) (NP (NN MSUD))) (PP (IN in) (NP (DT the) (JJ general) (NN population)))) (VP (VBZ is) (NP-PRD (CD 1) (SYM :) (CD 185,000)) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (, ,) (CC and) (S (PP (IN in) (NP (NP (JJ certain) (NN population) (NNS groups)) (, ,) (PP (JJ such) (IN as) (NP (NP (NNS Mennonites)) (PP (IN of) (NP (NNP Pennsylvania))))))) (, ,) (NP-SBJ-1 (DT the) (NN incidence)) (VP (VBZ is) (VP (VBN estimated) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (PP-PRD (IN as) (ADJP (ADJP (JJ high)) (PP (IN as) (NP (CD 1) (SYM :) (CD 176)))))))) (PRN (-LRB- [) (NP (CD 2)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN BCKDH) (NN complex)) (, ,) (NP (NP (DT the) (JJ deficient) (NN enzyme)) (PP (IN in) (NP (NN MSUD))))) (, ,) (VP (VBZ consists) (PP (IN of) (NP (NP (CD three) (JJ catalytic) (NN proteins)) (, ,) (NP (NP (DT a) (NN decarboxylase) (PRN (-LRB- -LRB-) (NP (NN E1)) (-RRB- -RRB-))) (, ,) (NP (DT a) (NN dihydrolipoyl) (NN transacylase) (PRN (-LRB- -LRB-) (NP (NN E2)) (-RRB- -RRB-))) (, ,) (CC and) (NP (DT a) (NN dihydrolipoyl) (NN dehydrogenase) (PRN (-LRB- -LRB-) (NP (NN E3)) (-RRB- -RRB-))))))) (. .)) )
( (S (NP-SBJ (DT The) (NN E1) (NN component)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN heterotetramer)) (VP (VBN composed) (NP (-NONE- *)) (PP (IN of) (NP (NML (NML (CD two) (NN α)) (CC and) (NML (CD two) (NN β))) (NNS subunits))))) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN E1) (CC and) (NN E2)) (NNS components)) (VP (VBP are) (ADJP-PRD (JJ specific) (PP (IN to) (NP (NN BCKDH)))) (, ,) (SBAR-ADV (IN whereas) (S (NP-SBJ-1 (NN E3)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN used) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NML (NN pyruvate)) (CC and) (NML (NN α) (HYPH -) (NN ketoglutarate))) (NN dehydrogenase) (NNS complexes) (PRN (-LRB- [) (NP (CD 3)) (-RRB- ]))) (CC and) (NP (DT the) (NML (NN glycine) (NN cleavage)) (NN system) (PRN (-LRB- [) (NP (CD 4)) (-RRB- ])))))))))) (. .)) )
( (S (NP-SBJ-1 (NN BCKDH)) (VP (VBZ is) (ADVP (RB also)) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NP (CD two) (JJ regulatory) (NN proteins)) (, ,) (NP (NP (DT a) (JJ specific) (NN kinase)) (CC and) (NP (DT a) (NN phosphatase)))) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP regulate) (NP (NP (DT the) (NN activity)) (PP (IN of) (NP (DT this) (NN enzyme)))) (PP-MNR (IN through) (NP (NP (DT a) (NML (NML (NN phosphorylation) (PRN (-LRB- -LRB-) (NP (NN inactivation)) (-RRB- -RRB-))) (CC and) (NML (NN dephosphorylation) (PRN (-LRB- -LRB-) (NP (NN activation)) (-RRB- -RRB-)))) (NN cycle)) (PP (IN of) (NP (DT the) (NN E1) (NN α) (NN subunit)))))))))) (PRN (-LRB- [) (NP (CD 5) (, ,) (CD 6)) (-RRB- ])))) (. .)) )
( (S (S (NP-SBJ-1 (NP (NNS Mutations)) (PP (IN in) (NP (NP (DT the) (NNS genes)) (PP (IN of) (NP (NP (DT the) (NML (NN E1) (CC and) (NN E2)) (NNS subunits)) (PP (IN of) (NP (NN BCKDH)))))))) (VP (VBP have) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)))))) (, ,) (S (ADVP (RB however)) (, ,) (NP-SBJ (NP (DT the) (NN majority)) (PP (IN of) (NP (NP (NN MSUD) (NNS mutations)) (VP (VBN identified) (NP (-NONE- *)) (ADVP (RB thus) (RB far)))))) (VP (VBP are) (PP-PRD (IN in) (NP (DT the) (NN E2) (NN subunit))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 7)) (-RRB- ])))) (. .)) )
( (S (PP-TMP (IN To) (NP (NN date))) (, ,) (NP-SBJ-1 (NP (NNS cases)) (PP (IN of) (NP (NN MSUD)))) (VP (VBP have) (RB not) (VP (VBN been) (VP (VBN associated) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NNS defects)) (PP (IN in) (NP (DT the) (NML (NML (JJ regulatory) (NN kinase)) (CC and) (NML (NN phosphatase))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NP (JJ Current) (NN management)) (PP (IN of) (NP (NN MSUD) (NNS patients)))) (VP (VBZ relies) (PP (IN on) (NP (NP (DT a) (JJ strict) (JJ lifelong) (JJ dietary) (NN restriction)) (PP (IN of) (NP (NN protein) (CC or) (NN BCAA))))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 8)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (NP (PDT Such) (DT a) (JJ dietary) (NN management)) (PP (IN of) (NP (DT the) (NN disease)))) (, ,) (ADVP (RB however)) (, ,) (VP (VBZ is) (RB not) (ADJP-PRD (RB entirely) (JJ satisfactory)) (PP-TMP (ADVP (RB especially)) (IN in) (NP (NP (NNS times)) (PP (IN of) (NP (NP (JJ metabolic) (NN decompensation)) (PP (IN due) (IN to) (NP (NP (NN infection)) (, ,) (NP (NNS injuries)) (CC and) (NP (JJ other) (NNS stressors))))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN spite)) (PP (IN of) (NP (JJ dietary) (NN intervention))))) (, ,) (S (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (JJ significant) (NN mortality)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN MSUD))))))) (CC and) (S (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (JJ high) (NN incidence)) (PP (IN of) (NP (JJ mental) (NN retardation)))) (PP-LOC (IN in) (NP (NNS survivors))) (PRN (-LRB- [) (NP (CD 9)) (-RRB- ]))))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (NP (DT the) (JJ central) (NN role)) (PP (IN of) (NP (DT the) (NN liver))) (PP (IN in) (NP (NML (NN amino) (NN acid)) (NN metabolism)))) (CC and) (NP (NP (ADJP (JJ moderate) (SYM /) (JJ high)) (NNS levels)) (PP (IN of) (NP (NP (NN BCKDH) (NN activity)) (PP-LOC (IN in) (NP (JJ human) (NN liver)))))) (PRN (-LRB- [) (NP (NP (CD 10)) (PP (SYM -) (NP (CD 12)))) (-RRB- ])))) (, ,) (NP-SBJ-1 (NP (DT a) (JJ few) (NNS cases)) (PP (IN of) (NP (NN MSUD)))) (VP (VBP have) (ADVP-TMP (RB recently)) (VP (VBN been) (VP (VBN treated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN liver) (NN transplantation))) (PRN (-LRB- [) (NP (NP (CD 13)) (PP (SYM -) (NP (CD 16)))) (-RRB- ]))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (NP (DT the) (NML (JJ short) (HYPH -) (NN term)) (NN outcome)) (PP (IN of) (NP (NN liver) (NN transplantation)))) (VP (VBZ is) (ADJP-PRD (JJ encouraging))))) (, ,) (NP-SBJ-1 (NP (NML (JJ long) (HYPH -) (NN term)) (NNS effects)) (PP (IN of) (NP (DT this) (NN approach)))) (VP (VBP are) (RB not) (VP (VBN known) (NP-1 (-NONE- *)))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-1 (DT these) (NNS patients)) (VP (VBP are) (ADVP-TMP (RB now)) (VP (VBN required) (NP-1 (-NONE- *)) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB take) (NP (NN immunosuppressant) (NNS drugs)) (PP-TMP (IN for) (NP (NP (DT the) (NN rest)) (PP (IN of) (NP (PRP$ their) (NNS lives))))) (, ,) (PP (ADVP-TMP (RB often)) (IN with) (NP (JJ undesirable) (NN side) (NNS effects)))))))) (. .)) )
( (S (ADVP (RB Moreover)) (, ,) (NP-SBJ (NP (NP (DT the) (NN cost)) (VP (VBN associated) (NP (-NONE- *)) (PP (IN with) (NP (NN liver) (NN transplantation))))) (CC and) (NP (NP (DT the) (NN availability)) (PP (IN of) (NP (NN donor) (NNS livers))))) (VP (VBP are) (NP-PRD (NP (JJ additional) (VBG limiting) (NNS factors)) (PP (IN for) (NP (NP (DT the) (NN practicality)) (PP (IN of) (NP (NP (NN treatment)) (PP (IN of) (NP (DT this) (NN disease))))))))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (DT the) (JJ current) (JJ unsatisfactory) (NNS options)) (PP (IN for) (NP (NP (DT the) (NN treatment)) (PP (IN of) (NP (NN MSUD))))))) (, ,) (NP-SBJ (EX there)) (VP (VBZ is) (NP-PRD (NP (DT a) (NN need)) (PP (IN for) (NP (NP (VBN improved) (NNS therapies)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB combat) (NP (DT this) (NN disease)))))))))) (. .)) )
( (S (NP-SBJ (NP (DT An) (NN obstacle)) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG developing) (NP (NP (JJ novel) (NNS treatments)) (PP (IN for) (NP (NN MSUD)))))))) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (DT a) (JJ suitable) (NN animal) (NN model)) (SBAR (WHADVP-1 (-NONE- *0*)) (S (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB perform) (NP (JJ necessary) (JJ preclinical) (NNS studies)) (ADVP-MNR-1 (-NONE- *T*))))))))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (DT a) (NML (NNP Hereford) (NN calf)) (NN model)) (PP (IN with) (NP (NN MSUD)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 17)) (PP (SYM -) (NP (CD 19))) (-RRB- ]))))))) (, ,) (NP-SBJ-2 (DT this) (NN model)) (VP (VBZ is) (ADJP-PRD (CC neither) (ADJP (RB readily) (JJ available)) (CC nor) (ADJP (JJ practical) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB perform) (NP (JJ preclinical) (NNS studies)))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ (NP (NN comparison)) (PP (IN of) (NP (NP (DT this) (NN animal) (NN model)) (PP (IN with) (NP (JJ human) (NN MSUD)))))) (VP (VBZ has) (VP (VBN shown) (NP (NP (DT some) (NNS differences)) (PP (IN in) (NP (NP (DT the) (NN pathology)) (PP (IN of) (NP (DT the) (NN disease)))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG making) (S (NP-SBJ (DT this) (NN animal)) (NP-PRD (NP (DT a) (ADJP (RBR less) (JJ desirable)) (NN model)) (PP (IN for) (NP (DT the) (JJ human) (NN disease))))))))) (. .)) )
( (S (ADVP-TMP (RB Recently)) (, ,) (NP-SBJ-2 (NP (ADJP (NP (NP (DT a) (NML (NN N) (HYPH -) (NN ethyl)) (HYPH -) (NN N) (HYPH -) (NN nitrosourea)) (-LRB- -LRB-) (NP (NN ENU))) (-RRB- -RRB-) (HYPH -) (VBN induced)) (NN mutant) (NN mouse)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (ADVP (RB phenotypically)) (VP (VBZ resembles) (NP (JJ human) (NN MSUD)))))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-2 (-NONE- *)) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ (NP (DT the) (NN mutation)) (PP (IN in) (NP (DT this) (NN model)))) (VP (VBZ disrupts) (NP (NP (DT a) (NN splice) (NN site)) (PP-LOC (PP (IN in) (NP (NP (DT the) (JJ mitochondrial) (NML (NML (NML (VBN branched) (HYPH -) (NN chain)) (NN aminotransferase)) (-LRB- -LRB-) (NML (NN BCAT)))) (-RRB- -RRB-) (NN gene))) (, ,) (RB not) (PP (IN in) (NP (NP (NN BCKDH)) (, ,) (NP (NP (DT the) (JJ deficient) (NN enzyme)) (PP (IN in) (NP (NN MSUD))))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ (DT the) (NN mutation)) (VP (VBZ is) (RB not) (PP-LOC-PRD (IN in) (NP (NN BCKDH)))))) (, ,) (NP-SBJ (NP (DT the) (NN validity)) (PP (IN of) (NP (DT this) (NN mutant) (NN mouse) (NN line))) (PP (IN for) (NP (VBG modeling) (JJ human) (NN MSUD)))) (VP (VBZ is) (ADJP-PRD (JJ questionable))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN objective)) (PP (IN of) (NP (DT the) (JJ present) (NN study)))) (VP (VBD was) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (NP (ADJP (RB genetically) (VBN engineered)) (JJ murine) (NNS models)) (PP (IN of) (NP (NN MSUD)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP mimic) (NP (NP (DT the) (NN pathology)) (PP (IN of) (NP (NP (DT the) (ADJP (JJ classic) (CC and) (JJ intermediate)) (JJ variant) (NNS forms)) (PP (IN of) (NP (DT the) (JJ human) (NN disease)))))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (JJ classic) (NN model)) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (VBN targeted) (NN inactivation)) (PP (IN of) (NP (NP (DT the) (NN E2) (NN subunit)) (PP (IN of) (NP (NN BCKDH))))) (PP (IN by) (NP (JJ homologous) (NN recombination))) (PP (IN in) (NP (NML (NML (JJ embryonic)) (NN stem) (-LRB- -LRB-) (NML (NN ES))) (-RRB- -RRB-) (NNS cells))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN model)) (PP (IN of) (NP (JJ intermediate) (NN MSUD)))) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (JJ partial) (JJ transgenic) (NN rescue)) (PP (IN of) (NP (DT the) (NN E2) (NN gene) (NN knockout))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN report)) (VP (VBZ describes) (NP (NP (DT the) (NML (NN generation) (CC and) (NN characterization))) (PP (IN of) (NP (NP (DT these) (JJ murine) (NNS models)) (PP (IN of) (NP (NN MSUD))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS models)) (VP (MD will) (VP (VB allow) (PP (IN for) (NP (NP (DT the) (NN development)) (PP (IN of) (NP (NP (JJ novel) (NN treatment) (NNS approaches)) (, ,) (PP (JJ such) (IN as) (NP (NML (NML (NN gene)) (CC or) (NML (NN stem) (NN cell))) (NNS therapies))))))) (, ,) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (ADVP (RB ultimately)) (VP (VB cure) (NP (NN MSUD))))))) (. .)) )
( (HEADING (NP (NNS Methods))) )
( (S (NP-SBJ-1 (NP (DT All) (NNS studies)) (VP (VBG involving) (NP (NNS animals)))) (VP (VBD were) (VP (VBN reviewed) (CC and) (VBN approved) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (NNP University)) (PP (IN of) (NP (NP (NNP Pittsburgh) (POS 's)) (NML (NML (NNP Institutional) (NNP Animal)) (NNP Care) (CC and) (NNP Use)) (NNP Committee))))))) (. .)) )
( (HEADING (NP (NML (NN Gene) (NN knockout)) (NN production))) )
( (S (NP-SBJ-2 (NP (NP (DT A) (JJ genomic) (NN DNA) (NN subclone)) (PP (IN of) (NP (NN Strain) (NML (CD 129) (HYPH /) (NN SvJ)) (NN DNA)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD contained) (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (NP (NNS Exons) (NML (CD 4) (CC and) (CD 5))) (PP (IN of) (NP (DT the) (NML (NML (NN E2) (NN gene)) (CC and) (NML (NN flanking) (NN DNA)))))))))))) (VP (VBD was) (VP (VBN obtained) (NP-2 (-NONE- *)) (PP (IN from) (NP (NP (DT a) (NML (NN P1) (NN phage)) (NN library)) (PP (IN from) (NP (NNP Genome) (NNP Systems) (, ,) (NNP Inc.) (, ,) (PRN (-LRB- -LRB-) (NP (NP (NNP St.) (NNP Louis)) (, ,) (NP-LOC (NNP MO))) (: ;) (SYM ') (NP (NML (CD 3) (HYPH -) (NN Hit)) (NML (NNP Mouse) (NNP ES)) (NNP Library)) (POS ') (-RRB- -RRB-)))))))) (. .)) )
( (S (NP-SBJ-1 (DT A) (ADJP (JJ positive) (HYPH /) (JJ negative)) (NML (NN replacement) (NN type)) (NML (NN gene) (NN targeting)) (NN vector) (PRN (-LRB- [) (NP (CD 21)) (-RRB- ]))) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG replacing) (NP (NP (DT a) (NML (CD 1.67) (NN kb)) (NML (NN EcoRV) (HYPH -) (NN Smal)) (NN fragment)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD included) (NP (NP (NP (NP (DT a) (NN portion)) (PP (IN of) (NP (NN Exon) (CD 4)))) (CC and) (NP (NP (DT all)) (PP (IN of) (NP (NN Exon) (CD 5))))) (PP (IN with) (NP (NP (DT the) (NN PGKneo) (NN marker) (NN gene) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB See) (NP (NN Fig.) (NN 1A)))) (-RRB- -RRB-))) (PP (IN from) (NP (DT the) (NN pPNT) (NN vector)))))) (PRN (-LRB- [) (NP (CD 22)) (-RRB- ]))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NN targeting) (NN construct)) (VP (VBD was) (VP (VP (VBN linearized) (NP-1 (-NONE- *)) (PP (IN with) (NP (NN NotI)))) (CC and) (VP (VBN electroporated) (NP-1 (-NONE- *)) (PP (IN into) (NP (NN R1) (NN ES) (NNS cells) (PRN (-LRB- [) (NP (CD 23)) (-RRB- ])))) (PP (IN under) (NP (NP (NNS conditions)) (VP (VBN described) (NP (-NONE- *)) (ADVP-TMP (RB previously)) (PRN (-LRB- [) (NP (CD 24)) (-RRB- ])))))))) (. .)) )
( (S (NP-SBJ-1 (NN ES) (NNS cells)) (VP (VBD were) (VP (VBN selected) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (NN G418) (PRN (-LRB- -LRB-) (NP (NP (CD 300) (NN μg)) (PP (SYM /) (NP (NN ml)))) (: ;) (NP (NP (NNP Life) (NNP Technologies) (NNP Inc.)) (, ,) (NP-LOC (NNP Gaithersburg)) (, ,) (NP-LOC (NNP MD))) (-RRB- -RRB-))) (CC and) (NP (NN gancyclovir) (-LRB- -LRB-) (NP (CD 2) (NN μM)) (: ;) (NP (NP (NN gift)) (PP (IN of) (NP (NP (NNP Syntex)) (, ,) (NP-LOC (NNP Palo) (NNP Alto)) (, ,) (NP-LOC (NNP CA))))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Doubly) (JJ resistant)) (NNS clones)) (VP (VBD were) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN gene) (NN targeting))) (PP-MNR (IN by) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NN BglI) (VBN digested) (JJ genomic) (NN DNA))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (VP (VBN hybridized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT an) (ADJP (NP (NN Exon) (CD 6)) (JJ specific)) (NN probe)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD was) (ADJP-PRD (JJ external) (PP (IN to) (NP (DT the) (NML (NN gene) (NN targeting)) (NN construct))))))))))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Correctly) (VBN targeted)) (NN ES) (NNS cells)) (VP (VBD were) (VP (VBN injected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS blastocysts))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (JJ chimeric) (NNS mice)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ standard) (NNS procedures))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Heterozygous) (NN offspring)) (PP (IN from) (NP (ADJP (NN germline) (JJ competent)) (NNS chimeras)))) (VP (VBD were) (VP (VBN intercrossed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NML (UCP (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM -)) (-RRB- -RRB-))) (CC and) (ADJP (JJ homozygous))) (NN knockout) (PRN (-LRB- -LRB-) (NP (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-))) (NNS mice))))))) (. .)) )
( (S (PP (IN At) (NP (DT all) (NNS generations))) (, ,) (NP-SBJ-1 (NML (SYM +) (HYPH /) (SYM -)) (VBG breeding) (NNS pairs)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (NNS Results)) (VP (VBN presented) (NP (-NONE- *)) (ADVP (RB here)))) (VP (VBP are) (PP-PRD (IN from) (NP (NP (NNS mice)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (DT the) (NML (NN F2) (SYM +)) (NNS generations))))))) (. .)) )
( (S (NP-SBJ (DT All) (NNS animals)) (VP (VBD were) (PP-PRD (IN of) (NP (DT a) (VBN mixed) (NML (NML (NN C57BL) (HYPH /) (NN 6J)) (SYM ×) (NML (NN Strain) (NN 129Sv) (HYPH /) (NN SvJ))) (JJ genetic) (NN background)))) (. .)) )
( (HEADING (NP (NN Figure) (CD 1))) )
( (CAPTION (NP (NN E2) (NML (NN gene) (NN knockout)) (NN mouse) (NN production) (. .))) )
( (CAPTION (NP (LST (LS A)) (, ,) (NP (NML (NN Gene) (NN targeting)) (NN strategy)) (VP (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG targeting) (NP (DT the) (NN E2) (NN locus))))) (PP-LOC (IN in) (NP (NN mouse) (NN ES) (NNS cells)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NN targeting) (NN construct)) (VP (VBD was) (VP (VBN designed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB delete) (NP (NP (CD 1.67) (NN kb)) (PP (IN of) (NP (NN sequence)))) (PP (IN between) (NP (NP (NP (DT an) (NN EcoRV) (NN site)) (PP-LOC (IN in) (NP (NN Exon) (CD 4)))) (CC and) (NP (NP (DT a) (NN Smal) (NN site)) (PP-LOC (IN in) (NP (NN intron) (CD 5))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NML (JJ wild) (NN type)) (NN E2) (NN gene)) (VP (VBZ contains) (NP (NP (DT an) (NML (QP (SYM ~) (CD 16)) (NN kb)) (NN BglI) (NN restriction) (NN fragment)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ hybridizes) (PP (IN to) (NP (DT the) (ADJP (NP (NN Exon) (CD 6)) (JJ specific)) (NN probe)))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT A) (ADJP (RB correctly) (VBN targeted)) (NN E2) (NN locus)) (VP (VBZ harbors) (NP (NP (DT an) (NML (QP (SYM ~) (CD 11)) (NN kb)) (NN BglI) (NN restriction) (NN fragment)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ hybridizes) (PP (IN to) (NP (DT the) (JJ same) (NN probe)))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (NP-SBJ (DT the) (NN probe)) (VP (MD will) (RB not) (VP (VB detect) (NP (NP (JJ random) (NN integration)) (PP (IN of) (NP (DT the) (NN targeting) (NN vector)))) (SBAR-PRP (IN because) (S (NP-SBJ (PRP it)) (VP (VBZ is) (ADJP-PRD (JJ external) (PP (IN to) (NP (DT the) (NN targeting) (NN vector)))))))))))) (. .))) )
( (CAPTION (NP (LST (LS B)) (, ,) (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (ADJP (NN Bgll) (VBN digested)) (JJ genomic) (NN DNA)) (VP (VBN derived) (NP (-NONE- *)) (PP (PP (IN from) (NP (NP (DT the) (JJ parental) (NML (JJ wild) (NN type)) (NML (NN ES) (NN cell)) (NN line) (PRN (-LRB- -LRB-) (NP (NN R1)) (-RRB- -RRB-))) (, ,) (NP (DT a) (JJ heterozygous) (VBN targeted) (NML (NN ES) (NN cell)) (NN line) (PRN (-LRB- -LRB-) (NP (CD 362)) (-RRB- -RRB-))))) (, ,) (CC and) (PP (IN from) (NP (NML (UCP (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM -)) (-RRB- -RRB-))) (CC and) (ADJP (JJ homozygous))) (NN knockout) (PRN (-LRB- -LRB-) (NP (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-))) (NNS mice))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT The) (NN blot)) (VP (VBD was) (VP (VBN hybridized) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT an) (ADJP (NP (NN Exon) (CD 6)) (JJ specific)) (NN probe))))) (. .))) )
( (CAPTION (NP (LST (LS C)) (, ,) (NP (JJ Immunohistochemical) (NN analysis)) (PP (IN of) (NP (NP (ADJP (JJ fresh) (VBN frozen)) (NN liver) (NNS sections)) (PP (IN from) (NP (NML (NML (NML (NN control) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (CC and) (NML (NN E2))) (NN knockout) (PRN (-LRB- -LRB-) (NP (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-))) (NML (JJ postnatal) (NN day) (CD 1)) (NN mouse) (NNS pups))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Sections)) (VP (VBD were) (VP (VBN stained) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN E2))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (DT an) (ADJP (NN E2) (JJ specific)) (NN antibody) (PRN (-LRB- -LRB-) (ADJP (JJ green)) (-RRB- -RRB-))) (CC and) (NP (DT a) (JJ nuclear) (NN stain) (PRN (-LRB- -LRB-) (ADJP (JJ blue)) (-RRB- -RRB-)))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (NP (NP (DT the) (JJ complete) (NN absence)) (PP (IN of) (NP (NN E2) (NN immunoreactivity)))) (PP-LOC (IN in) (NP (NP (DT the) (NN section)) (PP (IN from) (NP (DT the) (NN knockout) (NN mouse)))))) (. .))) )
( (CAPTION (S (LST (LS D)) (, ,) (NP-SBJ-1 (JJ Similar) (NNS results)) (VP (VBD were) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN upon) (NP (NP (JJ immunohistochemical) (NN analysis)) (PP (IN of) (NP (JJ primary) (NML (NML (NN mouse) (JJ embryonic) (NNS fibroblasts)) (-LRB- -LRB-) (NML (NNS MEFs))))))))) (-RRB- -RRB-) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (ADJP (RB readily) (JJ detectable)) (NN signal)) (PP (IN for) (NP (NN E2))) (PP-LOC (IN in) (NP (DT the) (NN control) (NNS cells)))) (VP (VBD was) (ADJP-PRD (JJ present) (PP (IN in) (NP (NP (DT a) (NN pattern)) (ADJP (JJ characteristic) (PP (IN of) (NP (NP (NNS mitochondria)) (, ,) (NP (NP (DT the) (JJ subcellular) (NN location)) (PP (IN of) (NP (NN BCKDH)))))))))))))) (. .))) )
( (HEADING (NP (NP (NN Production)) (PP (IN of) (NP (JJ transgenic) (NNS mice))))) )
( (S (NP-SBJ-1 (JJ Standard) (JJ molecular) (NNS techniques)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB assemble) (NP (NP (DT the) (JJ transgenic) (NN construct)) (, ,) (NP (NN pTRE) (HYPH -) (NN E2)))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN transgene)) (VP (VBZ contains) (NP (NP (NP (DT the) (NN tetracycline) (JJ responsive) (NML (NN hCMV) (SYM *) (HYPH -) (CD 1)) (NN promoter)) (-LRB- [) (VP (VBG consisting) (PP (IN of) (NP (NP (DT the) (NML (NML (NN tetracycline) (JJ responsive) (NN element)) (-LRB- -LRB-) (NML (NN TRE)))) (-RRB- -RRB-) (CC and) (NP (NP (DT a) (JJ minimal) (NN hCMV) (NN promoter) (-RRB- ]) (PRN (-LRB- [) (NP (CD 25)) (-RRB- ]))) (PP (IN from) (NP (NN pTRE2))) (PRN (-LRB- -LRB-) (NP (NP (NNP Clontech) (NNP Inc.)) (, ,) (NP-LOC (NNP Mt.) (NNP View)) (, ,) (NP-LOC (NNP CA))) (-RRB- -RRB-))))))) (, ,) (NP (NP (NP (DT a) (JJ chimeric) (NN intron)) (PP (IN from) (NP (NN pCI))) (PRN (-LRB- -LRB-) (NP (NNP Promega)) (-RRB- -RRB-))) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB increase) (NP (NN message) (NML (NN stability) (CC and) (NN expression))) (PRN (-LRB- [) (NP (CD 26) (, ,) (CD 27)) (-RRB- ]))))))) (, ,) (NP (NP (NP (DT a) (NN Kozak) (NN consensus) (NN sequence)) (PP-LOC (IN at) (NP (DT the) (NN initiation) (NN codon)))) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB optimize) (NP (NN translation)) (PRN (-LRB- [) (NP (CD 28)) (-RRB- ]))))))) (, ,) (NP (NP (DT the) (JJ human) (NN E2) (NN cDNA)) (SBAR (WHNP-3 (WDT which)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ has) (VP (VBN been) (VP (VBN modified) (NP-3 (-NONE- *)) (S-PRP (NP-SBJ-3 (-NONE- *PRO*)) (VP (TO to) (VP (VB contain) (NP (NP (DT a) (QP (CD 4) (SYM ×)) (NN alanine) (NN linker)) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (DT a) (NML (NN c) (HYPH -) (NN myc)) (NN epitope) (NN tag)) (PP-LOC (IN at) (NP (DT the) (NN carboxy) (NN terminus)))) (SBAR (WHNP-4 (-NONE- *0*)) (S (NP-SBJ-4 (-NONE- *T*)) (VP (TO to) (VP (VB facilitate) (NP (NN detection))))))))))))))))))) (, ,) (CC and) (NP (NP (DT an) (NN SV40) (JJ late) (NN polyadenylation) (NN sequence)) (PP (IN from) (NP (NN pCI))) (PP (IN for) (NP (VBN enhanced) (NN mRNA) (NML (NN stability) (CC and) (NN translation))))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (CD 2.48) (NN kb)) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene)) (VP (VBD was) (VP (VP (VP (VBN purified) (NP-1 (-NONE- *)) (PP (IN from) (NP (NN vector) (NNS sequences))) (PP (VBG following) (NP (NP (NN digestion)) (PP (IN with) (NP (NN XhoI) (CC and) (NN BamHI)))))) (CC and) (VP (VBN injected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NML (NML (NML (NN C57BL) (HYPH /) (NN 6J)) (CC or) (NML (NN C57BL) (HYPH /) (NN 6J))) (SYM ×) (NN Strain)) (NN 129SvEv) (NN mouse) (NNS embryos))))) (PP-LOC (IN at) (NP (NP (DT the) (JJ transgenic) (NN core) (NNS facilities)) (PP (IN of) (NP (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh)))) (CC and) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Cincinnati)))))))) (, ,) (ADVP (RB respectively)))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Genomic) (NN DNA)) (PP (IN from) (NP (NP (DT the) (NN tail)) (PP (IN of) (NP (NNS mice)))))) (VP (VBD was) (VP (VBN screened) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NNP Southern) (NN blot)) (NN analysis))) (PP (VBG following) (NP (NP (NP (NN digestion)) (PP (IN with) (NP (NN EcoRI)))) (CC and) (NP (NP (NN hybridization)) (PP (IN to) (NP (NP (DT an) (NML (QP (SYM ~) (CD 400)) (NN bp)) (NN probe)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NP (DT the) (NN SV40) (NN portion)) (PP (IN of) (NP (DT the) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene))))))))))))) (. .)) )
( (HEADING (NP (NP (NN Production)) (PP (IN of) (NP (JJ intermediate) (NN MSUD) (JJ murine) (NN model))))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ various) (NML (NN TRE) (HYPH -) (NN E2)) (JJ transgenic) (NNS lines)) (VP (VBN produced) (NP (-NONE- *)))) (VP (VBD were) (VP (VBN mated) (NP-1 (-NONE- *)) (ADVP (RB independently)) (PP (IN to) (NP (NP (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ heterozygous) (PP (IN for) (NP (CC both) (NP (DT the) (NN E2) (NN knockout)) (CC and) (NP (DT the) (NML (NN LAP) (HYPH -) (NN tTA)) (NN transgene)))))))))) (PRN (-LRB- [) (NP (NN Tg) (PRN (-LRB- -LRB-) (NP (NN tTALap)) (-RRB- -RRB-)) (NML (NN Bjd) (HYPH /) (NN J)) (: ;) (NN Stock) (CD 3272)) (: ;) (NP (NP (DT The) (NNP Jackson) (NNP Laboratory)) (, ,) (NP-LOC (NNP Bar) (NNP Harbor)) (, ,) (NP-LOC (NNP ME))) (: ;) (NP (NML (NML (NN NMRI)) (SYM ×) (NML (NN FVB)) (SYM ×) (NML (NN C57BL) (HYPH /) (NN 6J))) (NN background)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (NN Interbreeding)) (PP (IN of) (NP (NP (NNS animals)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ heterozygous) (PP (IN for) (NP (NP (DT both) (NNS transgenes)) (CC and) (NP (DT the) (NN knockout))))))))))) (VP (VBD resulted) (PP (IN in) (NP (NP (DT the) (NN production)) (PP (IN of) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (DT a) (NN variety)) (PP (IN of) (NP (NNS genotypes))))) (PP (VBG including) (NP (NP (DT some) (NNS animals)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VP (VBD were) (ADJP-PRD (JJ homozygous) (PP (IN for) (NP (DT the) (NN knockout))))) (CC and) (VP (VBD were) (ADJP-PRD (JJ positive) (PP (IN for) (NP (DT both) (NNS transgenes)))) (PRN (-LRB- -LRB-) (S (NP-SBJ (PRP we)) (VP (VBP refer) (PP (IN to) (NP (DT this) (NN genotype))) (PP (IN as) (NP (DT the) (`` ``) (NN rescue) ('' '') (NN genotype))))) (-RRB- -RRB-))))))))))))) (. .)) )
( (S (SBAR-ADV (IN If) (S (NP-SBJ (NP (PRP$ our) (NN strategy)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG rescuing) (NP (NP (DT the) (JJ neonatal) (JJ lethal) (NN phenotype)) (PP (IN of) (NP (DT the) (NN knockout)))))))) (VP (VBD were) (ADJP-PRD (JJ successful))))) (, ,) (ADVP (RB then)) (NP-SBJ (NP (DT those) (JJ homozygous) (NN knockout) (NNS animals)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD had) (NP (DT both) (NNS transgenes)))))) (VP (MD would) (VP (VB survive) (PP-TMP (IN beyond) (NP (DT the) (JJ neonatal) (NN period))))) (. .)) )
( (HEADING (NP (NN Genotyping))) )
( (S (NP-SBJ-1 (DT All) (NNS mice)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NNP Southern) (NN blot)) (NN analysis))))) (. .)) )
( (S (NP-SBJ-1 (NP (JJ Genomic) (NNS DNAs)) (VP (VBN prepared) (NP (-NONE- *)) (PP-MNR (IN from) (NP (NN tail) (NNS snips))))) (VP (VBD were) (VP (VP (VBN digested) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT an) (JJ appropriate) (NN restriction) (NN enzyme)))) (, ,) (VP (NN size) (VBN fractionated) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NN agarose) (NN gel)) (NN electrophoresis)))) (, ,) (VP (VBN blotted) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN nylon)))) (, ,) (CC and) (VP (VBN probed) (NP-1 (-NONE- *)) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (JJ standard) (NNS procedures))))))) (. .)) )
( (HEADING (NP (NN Immunohistochemistry))) )
( (S (NP-SBJ-2 (JJ Primary) (NN mouse) (JJ embryonic) (NNS fibroblasts)) (VP (VBD were) (VP (VBN prepared) (NP-2 (-NONE- *)) (PP-MNR (IN from) (NP (JJ embryonic) (NML (NN day) (NML (SYM ~) (NML (NML (CD 16.5)) (PP (SYM –) (NP (CD 18.5)))))) (NNS fetuses))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN described) (NP-1 (-NONE- *))))) (PRN (-LRB- [) (NP (CD 29)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (NNS Fibroblasts)) (VP (VBD were) (VP (VP (VBN passed) (NP-1 (-NONE- *)) (PP (IN onto) (NP (NN glass)))) (, ,) (VP (VBN fixed) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NML (CD 2) (NN %)) (NN paraformaldehyde))) (PP-MNR (IN in) (NP (NN PBS))) (PP-TMP (IN for) (NP (CD 10) (NNS minutes)))) (, ,) (VP (VBN permeabilized) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NP (NML (CD 2) (NN %)) (NN paraformaldehyde)) (VP (VBG containing) (NP (NML (CD 0.1) (NN %)) (NN Triton) (NN X100))))) (PP-TMP (IN for) (NP (CD 10) (NNS minutes)))) (CC and) (VP (VBD washed) (NP-TMP (CD three) (NNS times)) (PP-MNR (IN in) (NP (NP (NN PBS)) (VP (VBG containing) (NP (NP (NML (CD 0.5) (NN %)) (NN BSA)) (CC and) (NP (NML (CD 0.15) (NN %)) (NN glycine))) (, ,) (NP-ADV (NN pH) (CD 7.4)) (PRN (-LRB- -LRB-) (NP (NN Buffer) (NN A)) (-RRB- -RRB-)))))))) (. .)) )
( (S (PP (VBG Following) (NP (NP (NP (DT a) (NML (CD 30) (NN min)) (NN incubation)) (PP (IN with) (NP (VBN purified) (NN goat) (NN IgG) (PRN (-LRB- -LRB-) (NP (NP (CD 50) (-LRB- -LRB-) (NN μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))) (PP (IN at) (NP (CD 25) (NN °C)))) (CC and) (NP (NP (CD three) (JJ additional) (NNS washes)) (PP (IN with) (NP (NN Buffer) (NN A)))))) (, ,) (NP-SBJ-1 (NNS cells)) (VP (VBD were) (VP (VBN incubated) (NP-1 (-NONE- *)) (PP-TMP (IN for) (NP (CD 60) (NN min))) (PP (IN with) (NP (NP (ADJP (NN E2) (HYPH -) (JJ specific)) (NN antiserum) (PRN (-LRB- [) (NP (CD 30)) (-RRB- ]))) (PP (IN at) (NP (NP (CD 1) (NN μg)) (PP (SYM /) (NP (NN ml))))))) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBN followed) (NP-2 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (CD three) (NNS washes)) (PP (IN in) (NP (NN Buffer) (NN A)))) (CC and) (NP (NP (NML (CD 60) (NN minute)) (NN incubation)) (PP (IN in) (NP (ADJP (RB fluorescently) (VBN labeled)) (JJ second) (NN antibody))))))))) (PRN (-LRB- -LRB-) (NP (NP (QP (CD 1) (SYM –) (CD 2)) (NN μg)) (PP (SYM /) (NP (NN ml)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NNS cells)) (VP (VBD were) (ADVP (RB then)) (VP (VP (VBN washed) (NP-1 (-NONE- *)) (NP-TMP (CD six) (NNS times) (PRN (-LRB- -LRB-) (NP-TMP (NP (CD 5) (NN min)) (PP (SYM /) (NP (NN wash)))) (-RRB- -RRB-))) (PP-MNR (IN in) (NP (NN Buffer) (NN A)))) (CC and) (VP (ADVP (RB then)) (VBN mounted) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (NN gelvatol) (PRN (-LRB- -LRB-) (NP (NP (NNP Monsanto)) (, ,) (NP-LOC (NNP St) (NNP Louis))) (-RRB- -RRB-))))))) (. .)) )
( (S (SBAR-TMP (WHADVP-1 (WRB When)) (S (NP-SBJ-2 (NP (NNS livers)) (PP (IN from) (NP (JJ newborn) (NNS pups)))) (VP (VBD were) (VP (VBN examined) (NP-2 (-NONE- *)) (ADVP-TMP-1 (-NONE- *T*)))))) (, ,) (NP-SBJ (NN fixation)) (VP (VBD was) (PP-PRD (IN by) (NP (NP (NP (NN immersion)) (PP (IN in) (NP (NML (CD 2) (NN %)) (NN paraformaldehyde)))) (VP (VBN followed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (NP (NP (NP (NN cryoprotection)) (CC and) (NP (NN shock) (NN freezing))) (PP (IN in) (NP (ADJP (NP (JJ liquid) (NN nitrogen)) (VBN cooled)) (NN isopentane)))) (CC and) (NP (NN sectioning) (PRN (-LRB- -LRB-) (NP (CD 5) (NNS microns)) (-RRB- -RRB-))))))))) (. .)) )
( (S (ADVP (RB Otherwise)) (NP-SBJ (NN processing)) (VP (VBD was) (PP-PRD (IN as) (PP (IN for) (NP (NP (DT the) (NNS cells)) (ADVP (RB above))))) (-LRB- -LRB-) (PP (IN without) (NP (DT the) (NML (NN fixation) (CC and) (NN permabilization)) (NNS steps)))) (-RRB- -RRB-) (. .)) )
( (HEADING (NP (NML (NN Amino) (NN acid)) (NN analysis))) )
( (S (NP-SBJ-1 (NN Blood)) (VP (VBD was) (VP (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (DT the) (JJ retroorbital) (NML (NN sinus) (CC or) (NN tail)) (NN vein)) (PP (IN of) (NP (NNS mice)))))) (CC and) (VP (VBN spotted) (NP-1 (-NONE- *)) (PP-MNR (IN on) (NP (NP (DT a) (NN filter) (NN paper)) (VP (ADVP (RB routinely)) (VBN used) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NP (NN blood) (NML (NN amino) (NN acid)) (NN analysis)) (PP (IN for) (NP (JJ prenatal) (NN screening))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Concentrations)) (PP (IN of) (NP (NP (NN BCAA)) (CC and) (NP (JJ other) (NN amino) (NNS acids)))) (PP (IN in) (NP (NN blood)))) (VP (VBD were) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ tandem) (NN mass) (NN spectrometry) (PRN (-LRB- -LRB-) (NP (NP (NNP Pediatrix) (NNP Screening)) (, ,) (NP-LOC (NNP Bridgeville)) (, ,) (NP-LOC (NNP PA))) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NP (NN Assay)) (PP (IN of) (NP (NN BCKDH) (NN activity))))) )
( (S (NP-SBJ-1 (NNS Livers)) (VP (VBD were) (VP (VP (VBN removed) (NP-1 (-NONE- *))) (, ,) (VP (VBN frozen) (NP-1 (-NONE- *)) (PP-MNR (IN in) (NP (JJ liquid) (NN nitrogen)))) (, ,) (CC and) (VP (VBN stored) (NP-1 (-NONE- *)) (PP (IN at) (NP (QP (HYPH -) (CD 80)) (NN °C)))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NP (DT the) (NN time)) (PP (IN of) (NP (NN enzyme) (NN assay))))) (, ,) (NP-SBJ-1 (NNS livers)) (VP (VBD were) (VP (VP (VBN thawed) (NP-1 (-NONE- *))) (, ,) (CC and) (VP (VBN homogenized) (NP-1 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (CD 1) (SYM :) (CD 9)) (, ,) (NP (NN w) (HYPH /) (NN v)) (-RRB- -RRB-)) (PP-MNR (IN in) (NP (NP (NML (CD 0.25) (NN M)) (NN sucrose)) (, ,) (NP (NP (NML (CD 10) (NN mM)) (NN Tris) (HYPH -) (NN HC1)) (, ,) (NP-ADV (NN pH) (CD 7.4)))))))) (. .)) )
( (S (S (NP-SBJ-1 (NN Liver) (NNS homogenates)) (VP (VBD were) (VP (VBN centrifuged) (NP-1 (-NONE- *)) (PP-MNR (IN at) (NP (QP (CD 600) (SYM ×)) (NN g))) (PP-TMP (IN for) (NP (CD 10) (NN min))) (PP-MNR (IN at) (NP (CD 4) (NN °C)))))) (CC and) (S (NP-SBJ-2 (DT the) (NN supernatant) (NN fraction)) (VP (VBD was) (VP (VBN saved) (NP-2 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB determine) (NP (DT the) (NN BCKDH) (NN activity)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN use)) (PP (IN of) (NP (NN tissue) (NNS homogenates)))) (VP (VBD was) (VP (VBN necessitated) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (DT the) (JJ limited) (NN availability)) (PP (IN of) (NP (NP (NN liver) (NN tissue)) (, ,) (PP (ADVP (RB particularly)) (IN from) (NP (JJ newborn) (NNS pups))))))))) (. .)) )
( (S (NP-SBJ-1 (NN BCKDH) (NN activity)) (VP (VBD was) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG measuring) (NP (NP (DT the) (NN release)) (PP (IN of) (NP (NN 14CO2)))) (PP (IN from) (NP (NML (NN α) (HYPH -) (NN keto) (PRN (-LRB- [) (NP (NP (CD 1)) (PP (SYM -) (NP (NN 14C)))) (-RRB- ]))) (NN isocaproate)))))) (SBAR-ADV (IN as) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN described) (NP-2 (-NONE- *)) (ADVP-TMP (RB previously)) (PRN (-LRB- [) (NP (CD 31)) (-RRB- ]))))))) (. .)) )
( (S (NP-SBJ (DT The) (JJ complete) (NN reaction) (NN mixture)) (VP (VBD contained) (PRN (-LRB- -LRB-) (NP (NP (JJ final) (NN volume)) (NP (CD 1) (NN ml))) (-RRB- -RRB-)) (NP (NP (NP (NML (CD 30) (NN mM)) (NML (NN potassium) (NN phosphate)) (NN buffer)) (, ,) (NP-ADV (NN pH) (CD 7.4))) (, ,) (NP (NML (CD 0.20) (NN mM)) (NN α) (HYPH -) (NN ketoisocaproate)) (, ,) (NP (NML (CD 0.40) (NN mM)) (NN CoASH)) (, ,) (NP (NML (CD 0.40) (NN mM)) (NN thiamin) (NN pyrophosphate)) (, ,) (NP (NML (CD 2) (NN mM)) (NN NAD) (SYM +)) (, ,) (NP (NML (CD 2) (NN mM)) (NN dithiothreitol)) (, ,) (NP (NML (CD 5) (NN mM)) (NN Mg2) (SYM +)) (, ,) (NP (NP (QP (RB approximately) (CD 250,000)) (NN DPM)) (PP (IN of) (NP (NML (NN α) (HYPH -) (NN keto) (PRN (-LRB- [) (NP (NP (CD 1)) (PP (SYM -) (NP (NN 14C)))) (-RRB- ]))) (NN isocaproate)))) (, ,) (CC and) (NP (NP (CD 0.10) (NN ml)) (PP (IN of) (NP (NN liver) (NN homogenate) (PRN (-LRB- -LRB-) (NP (NML (QP (CD 2) (SYM –) (CD 3)) (NN mg)) (NN protein)) (-RRB- -RRB-))))))) (. .)) )
( (S (S (NP-SBJ-1 (NNS Assays)) (VP (VBD were) (VP (VBN carried) (NP-1 (-NONE- *)) (PRT (RP out)) (PP-TMP (IN for) (NP (CD 15) (NN min))) (PP-MNR (IN at) (NP (CD 37) (NN °C)))))) (, ,) (S (NP-SBJ-2 (NN 14CO2)) (VP (VBD was) (VP (VBN trapped) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN hydroxide)) (PP (IN of) (NP (NN Hyamine)))))))) (, ,) (CC and) (S (NP-SBJ-3 (NN radioactivity)) (VP (VBD was) (VP (VBN determined) (NP-3 (-NONE- *)) (PP-MNR (IN by) (NP (NML (JJ liquid) (NN scintillation)) (NN spectrometry)))))) (. .)) )
( (HEADING (NP (NML (NNP Western) (NN blot)) (NN analysis))) )
( (S (NP-SBJ-1 (NN Protein) (NNS extracts)) (VP (VBD were) (VP (VBN isolated) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NP (VBN homogenized) (NN liver)) (-LRB- -LRB-) (VP (VP (ADVP (RB freshly)) (VBN harvested) (NP (-NONE- *))) (CC and) (VP (NN flash) (VBN frozen) (NP (-NONE- *))))) (-RRB- -RRB-) (PP (IN of) (NP (ADJP (NP (NP (NN wildtype)) (, ,) (NP (NN Line) (NN 525A)) (, ,) (CC and) (NP (NN Line) (NN A))) (JJ transgenic)) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NN Protein) (PRN (-LRB- -LRB-) (NP (NP (CD 25) (NN μg)) (PP (IN per) (NP (NN sample)))) (-RRB- -RRB-))) (VP (VBD was) (VP (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN electrophoresis))) (PP-MNR (IN on) (NP (DT a) (NML (CD 10) (NN %)) (NML (NN SDS) (HYPH -) (NN PAGE)) (JJ Ready) (NN Gel) (PRN (-LRB- -LRB-) (NP (NNP Bio) (HYPH -) (NNP Rad)) (, ,) (NP-LOC (NNP Hercules)) (, ,) (NP-LOC (NNP CA)) (-RRB- -RRB-))))) (CC and) (VP (VBN transferred) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN PVDF) (NN membrane) (PRN (-LRB- -LRB-) (NP (NNP Sequi) (HYPH -) (NNP Blot)) (: ;) (NP (NNP Bio) (HYPH -) (NNP Rad)) (-RRB- -RRB-)))) (PP-MNR (IN via) (NP (NN electroblotting)))))) (. .)) )
( (S (NP-SBJ-1 (DT All) (NNS blots)) (VP (VBD were) (VP (VBN probed) (NP-1 (-NONE- *)) (PP (IN for) (NP (NN E2) (NN protein))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (NP (JJ polyclonal) (NN rabbit) (NN E2) (NNS antisera) (PRN (-LRB- -LRB-) (NP (CD 1) (SYM :) (CD 5,000)) (-RRB- -RRB-))) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ detects) (NP (CC both) (NML (NML (NN mouse) (PRN (-LRB- -LRB-) (NP (QP (SYM ~) (CD 47)) (NN kD)) (-RRB- -RRB-))) (CC and) (NML (JJ human) (PRN (-LRB- -LRB-) (NP (QP (SYM ~) (CD 54)) (NN kD)) (-RRB- -RRB-)))) (NN E2) (NNS subunits) (PRN (-LRB- -LRB-) (-LRB- [) (NP (CD 30)) (-RRB- ]) (: ;) (NP (NP (NN gift)) (PP (IN from) (NP (NP (NNP Dr.) (NNP Susan) (NNP Hutson)) (, ,) (NP-LOC (NML (NNP Wake) (NNP Forest)) (NNP University))))) (-RRB- -RRB-))))))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (VP (VBN re-probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT a) (NN rabbit) (NML (JJ anti-c) (HYPH -) (NN myc)) (NN tag) (NN antibody) (PRN (-LRB- -LRB-) (NP (CD 1) (SYM :) (CD 10,000)) (: ;) (NP (NP (NNP abCam)) (, ,) (NP-LOC (NNP Cambridge)) (, ,) (NP-LOC (NNP MA))) (: ;) (NP (NN cat.) (SYM #) (NN ab9106) (HYPH -) (CD 100)) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NNS Blots)) (VP (VBD were) (ADVP (RB also)) (VP (VBN re-probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (DT an) (NN antibody)) (PP (IN for) (NP (NN β) (HYPH -) (NN actin) (PRN (-LRB- -LRB-) (NP (CD 43) (NN kD)) (: ;) (NP (CD 1) (SYM :) (CD 10,000)) (: ;) (NP (NN abCam)) (: ;) (NP (NN cat.) (SYM #) (NN ab8227) (HYPH -) (CD 50)) (-RRB- -RRB-)))))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB allow) (PP (IN for) (NP (NN loading) (NNS comparisons)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (NN goat) (JJ anti-rabbit) (JJ secondary) (NN antibody)) (VP (VBN conjugated) (NP (-NONE- *)) (PP (IN to) (NP (NN horseradish) (NN peroxidase) (PRN (-LRB- -LRB-) (NP (CD 1) (SYM :) (CD 10,000)) (: ;) (NP (NP (NNP Novus)) (, ,) (NP-LOC (NNP Littleton)) (, ,) (NP-LOC (NNP CO))) (: ;) (NP (NN cat.) (SYM #) (NN NB730) (HYPH -) (NN H)) (-RRB- -RRB-)))))) (VP (VBD was) (VP (VP (VBN used) (NP-1 (-NONE- *)) (PP-PRP (IN for) (NP (NN detection))) (S-MNR (NP-SBJ (-NONE- *PRO*)) (VP (VBG using) (NP (DT the) (NML (NNP Western) (NNP Lightning)) (NN chemiluminescence) (NN reagent) (PRN (-LRB- -LRB-) (NP (NP (NNP Perkin) (NNP Elmer)) (, ,) (NP-LOC (NNP Boston)) (, ,) (NP-LOC (NNP MA))) (-RRB- -RRB-)))))) (CC and) (VP (VBN exposed) (NP-1 (-NONE- *)) (PP (IN to) (NP (NN X-ray) (NN film)))))) (. .)) )
( (HEADING (NP (JJ Statistical) (NNS analyses))) )
( (S (NP-SBJ-1 (DT All) (NML (NN BCAA) (CC and) (NN BCKDH)) (NN enzyme) (NN activity) (NNS data)) (VP (VBP are) (VP (VBN presented) (NP-1 (-NONE- *)) (PP-MNR (IN as) (NP (NP (DT the) (NN mean)) (CONJP (SYM +) (HYPH /) (SYM -)) (NP (NP (NP (DT the) (JJ standard) (NN error)) (PP (IN of) (NP (DT the) (NN mean)))) (-LRB- -LRB-) (NP (NN S.E.M.))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Differences)) (PP (IN between) (NP (NNS genotypes)))) (VP (VBD were) (VP (VBN compared) (NP-1 (-NONE- *)) (PP (IN by) (NP (NP (NNP Student) (POS 's)) (NN t) (NN test))) (PRN (-LRB- [) (NP (CD 32)) (-RRB- ])))) (. .)) )
( (HEADING (NP (NNS Results))) )
( (HEADING (NP (NP (NN Production)) (PP (IN of) (NP (NN E2) (NML (NN gene) (NN knockout)) (NNS mice))))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB create) (NP (NN E2) (NN knockout) (NNS mice))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (NN gene) (NN targeting)) (PP-LOC (IN in) (NP (NN mouse) (NN ES) (NNS cells))) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB disrupt) (NP (DT the) (NN E2) (NN gene)))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (JJ overall) (NN strategy)) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG disrupting) (NP (DT the) (NN E2) (NN gene)))))) (VP (VBZ is) (VP (VBN illustrated) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Fig.) (NN 1A))))) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN gene) (NN targeting)) (NN construct)) (VP (VBD was) (VP (VBN designed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB replace) (NP (NP (DT a) (NML (CD 1.67) (NN kb)) (NML (NN EcoRV) (HYPH /) (NN Smal)) (JJ genomic) (NN DNA) (NN fragment)) (VP (VBG encompassing) (NP (NP (NP (NN part)) (PP (IN of) (NP (NN Exon) (CD 4)))) (CC and) (NP (NP (DT all)) (PP (IN of) (NP (NN Exon) (CD 5))))))) (PP (IN with) (NP (DT the) (NN PGKneo) (JJ selectable) (NN marker) (NN cassette)))))))) (. .)) )
( (S (PP-TPC-1 (IN Of) (NP (NP (CD 522) (NML (NN ES) (NN cell)) (NNS clones)) (VP (VBN screened) (NP (-NONE- *)) (PP-PRP (IN for) (NP (NN targeting))) (PP-MNR (IN by) (NP (NML (NNP Southern) (NN blot)) (NN analysis)))))) (, ,) (NP-SBJ (NP (CD 29)) (PP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (CD 5) (NN %)) (-RRB- -RRB-))) (VP (VBD displayed) (NP (NP (DT the) (VBN predicted) (NML (NN restriction) (NN fragment) (NN length)) (NNS polymorphisms)) (ADJP (JJ indicative) (PP (IN of) (NP (NN gene) (VBG targeting))))) (PP-LOC (IN at) (NP (DT the) (NN E2) (NN locus)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN illustrated) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Fig.) (NML (NN 1A) (CC and) (NN 1B))))))) (, ,) (NP-SBJ (NP (DT an) (NN E2) (NML (NN Exon) (CD 6)) (JJ specific) (NN probe)) (, ,) (SBAR (WHNP-2 (WDT which)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ is) (ADJP-PRD (JJ external) (PP (IN to) (NP (DT the) (NN targeting) (NN construct)))))))) (, ,) (VP (VBZ hybridizes) (PP (IN to) (NP (NP (RB only) (DT a) (NML (QP (SYM ~) (CD 16)) (NN kb)) (NN BglI) (NN restriction) (NN fragment)) (PP (IN from) (NP (NP (DT the) (NML (JJ wild) (NN type)) (NN allele)) (PP-LOC (IN in) (NP (DT the) (JJ parental) (NN R1) (NML (NN ES) (NN cell)) (NN line)))))))) (. .)) )
( (S (PP-LOC (IN In) (NP (ADJP (RB correctly) (VBN targeted)) (NN ES) (NNS cells))) (, ,) (NP-SBJ (DT this) (NN probe)) (ADVP (RB also)) (VP (VBZ hybridizes) (PP (IN to) (NP (DT a) (NML (QP (SYM ~) (CD 11)) (NN kb)) (NN BglI) (NN restriction) (NN fragment)))) (. .)) )
( (S (NP-SBJ-1 (NN Targeting)) (VP (VBD was) (VP (VBN confirmed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (NP (JJ several) (JJ additional) (NN restriction) (NNS enzymes)) (CC and) (NP (NNS probes)))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ-1 (ADJP (RB Correctly) (VBN targeted)) (NN ES) (NNS cells)) (VP (VBD were) (VP (VBN microinjected) (NP-1 (-NONE- *)) (PP (IN into) (NP (NNS blastocysts))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (JJ chimeric) (NNS mice))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Chimerics)) (VP (VBD were) (VP (VBN bred) (NP-1 (-NONE- *)) (PP (IN to) (NP (NML (NN C57BL) (HYPH /) (NN 6J)) (NNS mice))))) (. .)) )
( (S (PP (VBG Following) (NP (NP (NN germline) (NN transmission)) (PP (IN of) (NP (DT the) (VBN targeted) (NN allele))))) (, ,) (NP-SBJ-1 (JJ heterozygous) (NNS mice)) (VP (VBD were) (VP (VBN interbred) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (UCP (NML (JJ wild) (NN type) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM -)) (-RRB- -RRB-))) (CC and) (ADJP (JJ homozygous) (PRN (-LRB- -LRB-) (NP (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-)))) (NNS animals))))))) (. .)) )
( (S (NP-SBJ-1 (NNS Mice)) (VP (VBD were) (VP (VBN genotyped) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NML (NNP Southern) (NN blot)) (NN analysis))))) (. .)) )
( (S (NP-SBJ (DT The) (ADJP (NP (NN Exon) (CD 6)) (JJ specific)) (NN probe)) (VP (VBN hybridized) (PP (PP (IN to) (NP (NP (NP (RB only) (DT a) (NML (QP (SYM ~) (CD 16)) (NN kb)) (NN BglI) (NN restriction) (NN fragment)) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM +)) (NNS mice)))) (, ,) (NP (NP (DT a) (NML (QP (SYM ~) (CD 11)) (NN kb)) (NN BglI) (NN fragment)) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (, ,) (CC and) (PP (IN to) (NP (NP (DT both)) (PP (IN of) (NP (DT these) (NNS fragments))) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM -)) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 1B)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-1 (NP (NNS Mice)) (ADJP (JJ homozygous) (PP (IN for) (NP (DT the) (NN E2) (NN mutation))))) (VP (VBD were) (VP (VBN born) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (DT the) (VBN expected) (NN frequency))))) (. .)) )
( (S (NP-SBJ (NP (NN Genotype) (NN analysis)) (PP (IN of) (NP (NP (NNS pups)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (NML (SYM +) (HYPH /) (SYM -)) (PP (IN by) (NP (SYM +) (HYPH /) (SYM -)))) (NNS matings))))))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NML (NML (SYM +) (HYPH /) (SYM +)) (, ,) (NML (SYM +) (HYPH /) (SYM -)) (, ,) (CC and) (NML (SYM -) (HYPH /) (SYM -))) (NNS mice)) (VP (VBD were) (ADJP-PRD (JJ present)) (PP-TMP (IN at) (NP (RB nearly) (DT the) (VBN expected) (NML (CD 1) (SYM :) (CD 2) (SYM :) (CD 1)) (NN frequency))))))) (. .)) )
( (S (PP-TPC-1 (IN Of) (NP (NP (DT the) (JJ initial) (CD 60) (NNS animals)) (VP (VBN genotyped) (NP (-NONE- *))))) (, ,) (S (S (NP-SBJ (NP (CD 19)) (PP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (CD 32) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (SYM +) (HYPH /) (SYM +)))) (, ,) (S (NP-SBJ (NP (CD 27)) (PP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (CD 45) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (SYM +) (HYPH /) (SYM -)))) (, ,) (CC and) (S (NP-SBJ (NP (CD 14)) (PP-1 (-NONE- *T*)) (PRN (-LRB- -LRB-) (NP (CD 23) (NN %)) (-RRB- -RRB-))) (VP (VBD were) (NP-PRD (SYM -) (HYPH /) (SYM -))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT the) (NN E2) (NN gene)) (VP (VBD was) (ADJP-PRD (JJ dispensable) (PP (IN for) (NP (JJ normal) (JJ embryonic) (NN development))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ (RB nearly) (DT all) (JJ homozygous) (NNS mice)) (VP (VBD died) (PP-TMP (IN in) (NP (DT the) (JJ perinatal) (NN period)))) (. .)) )
( (S (S (PP-TMP (ADVP (RB Immediately)) (VBG following) (NP (NN birth))) (, ,) (NP-SBJ (JJ homozygous) (NNS pups)) (VP (VBD were) (ADJP-PRD (JJ indistinguishable) (PP (IN from) (NP (PRP$ their) (NML (NML (SYM +) (HYPH /) (SYM +)) (CC and) (NML (SYM +) (HYPH /) (SYM -))) (NNS littermates)))))) (: ;) (S (NP-SBJ-1 (PRP they)) (VP (VBD were) (ADJP-PRD (ADJP (JJ vigorous)) (, ,) (ADJP (JJ active)) (CC and) (ADJP (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB suckle)))))))) (. .)) )
( (S (PP-TMP (IN By) (NP (NP (ADJP (ADJP (JJ mid)) (PP (IN to) (ADJP (JJ late)))) (NN day)) (PP (IN on) (NP (JJ postnatal) (NN day) (CD one))))) (, ,) (NP-SBJ (RBS most) (NML (SYM -) (HYPH /) (SYM -)) (NNS pups)) (VP (VP (VBD became) (ADJP-PRD (JJ moribund))) (CC and) (VP (VBD were) (ADJP-PRD (RB readily) (JJ identifiable) (SBAR (IN as) (S (NP-SBJ (PRP they)) (VP (VP (VBD were) (ADJP-PRD (JJ lethargic) (, ,) (JJ pale))) (, ,) (CC and) (VP (VBD exhibited) (NP (VBG gasping) (JJ respiratory) (NNS movements))))))))) (. .)) )
( (S (PP (IN With) (NP (JJ few) (NNS exceptions))) (, ,) (NP-SBJ (NML (SYM -) (HYPH /) (SYM -)) (NNS pups)) (VP (VBD died) (PP-TMP (IN within) (NP (NP (CD 72) (NNS hours)) (PP (IN of) (NP (NN birth)))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP have) (VP (VBN observed) (NP (NP (CD one) (JJ rare) (NML (SYM -) (HYPH /) (SYM -)) (NN pup)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD survived) (PP-TMP (IN to) (NP (JJ postnatal) (NN day) (CD 13))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN reason)) (PP (IN for) (NP (NP (DT the) (VBN prolonged) (NN survival)) (PP (IN of) (NP (DT this) (NN pup)))))) (VP (VBZ is) (ADJP-PRD (JJ unknown))) (. .)) )
( (HEADING (S (NP-SBJ (ADJP (NN E2) (JJ deficient)) (NNS mice)) (ADVP (RB accurately)) (VP (VBP model) (NP (JJ classic) (NN MSUD))))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB demonstrate) (SBAR (IN that) (S (NP-SBJ (DT the) (NML (NN gene) (NN targeting)) (NN event)) (VP (VBD created) (NP (DT a) (JJ true) (ADJP (NN E2) (JJ null)) (NN allele)))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD determined) (NP (NN BCKDH) (NN activity)) (PP-LOC (IN in) (NP (NP (NN liver) (NNS homogenates)) (PP (IN of) (NP (NP (NML (JJ postnatal) (NN day) (CD 1)) (NN mouse) (NNS pups)) (VP (VBN derived) (NP (-NONE- *)) (PP (IN from) (NP (NML (NML (SYM +) (HYPH /) (SYM -)) (PP (IN by) (NP (SYM +) (HYPH /) (SYM -)))) (NN mating) (NNS pairs))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2A)))))) (, ,) (NP-SBJ (NP (DT the) (NN BCKDH) (NN activity)) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM +)) (NNS mice)))) (VP (VBD was) (ADJP-PRD (RB readily) (JJ detectable))) (. .)) )
( (S (PP (IN In) (NP (JJ marked) (NN contrast))) (, ,) (NP-SBJ (NN BCKDH) (NN activity)) (VP (VBD was) (ADJP-PRD (RB completely) (JJ absent)) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NN mouse) (NNS livers)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN expected) (NP-1 (-NONE- *))))) (, ,) (NP-SBJ (NP (NNS homogenates)) (PP (IN from) (NP (NML (SYM +) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBD had) (NP (NP (QP (RB approximately) (PDT half)) (DT the) (NN activity)) (PP (IN of) (NP (PRP$ their) (NML (SYM +) (HYPH /) (SYM +)) (NNS littermates)))) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2A)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS results)) (PP (IN from) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBP are) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (DT that)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS humans)) (PP (IN with) (NP (JJ classic) (NN MSUD))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (HEADING (NP (NN Figure) (CD 2))) )
( (HEADING (NP (NP (JJ Biochemical) (NN characterization)) (PP (IN of) (NP (DT the) (JJ classic) (NN MSUD) (JJ murine) (NN model))) (. .))) )
( (CAPTION (NP (LST (LS A)) (, ,) (NP (NN BCKDH) (NN enzyme) (NN activity)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN of) (NP (JJ newborn) (NML (UCP (NML (NML (JJ wild) (NN type)) (NN control) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM +)) (-RRB- -RRB-))) (, ,) (ADJP (JJ heterozygous) (PRN (-LRB- -LRB-) (NP (SYM +) (HYPH /) (SYM -)) (-RRB- -RRB-))) (, ,) (CC and) (ADJP (JJ homozygous) (PRN (-LRB- -LRB-) (NP (SYM -) (HYPH /) (SYM -)) (-RRB- -RRB-)))) (NN knockout)) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NN Enzyme) (NN activity)) (VP (VP (VBD was) (ADJP-PRD (RB significantly) (JJ reduced)) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM -)) (NN liver))) (PP (VBN compared) (PP (IN to) (NP (SYM +) (HYPH /) (SYM +))))) (, ,) (CC and) (VP (VBD was) (PP-PRD (IN below) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (NN detection))))) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NN liver))))) (. .))) )
( (CAPTION (NP (LST (LS B)) (, ,) (NP (JJ Total) (NN BCAA) (NNS concentrations)) (PP-LOC (IN in) (NP (NP (NN blood)) (PP (IN of) (NP (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Total) (NN BCAA)) (VP (VBP represent) (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NN leucine) (, ,) (NN isoleucine) (, ,) (CC and) (NN valine))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (JJ Total) (NN BCAA) (NNS concentrations)) (PP (IN in) (NP (NP (NN blood)) (PP (IN from) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (VP (VBD were) (ADJP-PRD (RB significantly) (JJ elevated)) (PP (VBN compared) (PP (IN to) (NP (NP (SYM +) (HYPH /) (SYM +)) (CC and) (NP (SYM +) (HYPH /) (SYM -)))))) (. .))) )
( (CAPTION (NP (LST (LS C)) (, ,) (NP (NP (NN Ratio)) (PP (IN of) (NP (JJ total) (NN BCAA))) (PP (IN to) (NP (NN alanine))) (PP-LOC (IN in) (NP (NP (NN blood)) (PP (IN of) (NP (NNS mice)))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT This) (NN ratio)) (VP (VBD was) (ADJP-PRD (RB significantly) (JJ elevated)) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS mice))) (PP (VBN compared) (PP (IN to) (NP (NML (NML (SYM +) (HYPH /) (SYM +)) (CC and) (NML (SYM +) (HYPH /) (SYM -))) (NNS mice))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS numbers)) (PP (IN on) (NP (DT the) (NNS bars)))) (VP (VBZ indicates) (NP (NP (DT the) (NN number)) (PP (IN of) (NP (NP (NNS mice)) (VP (VBN analyzed) (NP (-NONE- *))))))) (. .))) )
( (CAPTION (FRAG (FRAG (NP (SYM *)) (, ,) (ADJP (ADJP (RB Significantly) (JJ different)) (PP (IN from) (NP (SYM +) (HYPH /) (SYM +))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-)))) (: ;) (FRAG (NP (SYM **)) (, ,) (ADJP (ADJP (RB significantly) (JJ different)) (PP (IN from) (NP (NP (SYM +) (HYPH /) (SYM +)) (CC and) (NP (SYM +) (HYPH /) (SYM -)))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-)))) (. .))) )
( (S (NP-SBJ-1 (NP (NN Immunohistochemistry)) (PP (IN with) (NP (DT an) (ADJP (NN E2) (JJ specific)) (NN antibody)))) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB examine) (NP (NN E2) (NN protein)) (PP-LOC (IN in) (NP (DT the) (NNS mice)))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NML (NN 1C) (CC and) (NN 1D))))))) (, ,) (NP-SBJ (JJ immunoreactive) (NN E2) (NN protein)) (VP (VBD was) (ADJP-PRD (JJ abundant)) (PP-LOC (IN in) (NP (NP (NP (NN liver)) (CC and) (NP (JJ embryonic) (NNS fibroblasts))) (PP (IN of) (NP (NML (SYM +) (HYPH /) (SYM +)) (NNS mice)))))) (. .)) )
( (S (PP (IN In) (NP (JJ marked) (NN contrast))) (, ,) (NP-SBJ (JJ immunoreactive) (NN E2) (NN protein)) (VP (VBD was) (ADJP-PRD (JJ absent)) (PP-LOC (IN in) (NP (NP (DT these) (JJ same) (NNS tissues)) (PP (IN of) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS mice)))))) (. .)) )
( (S (NP-SBJ (NML (JJ Homozygous) (NN E2) (NN knockout)) (NNS mice)) (VP (VBD had) (NP (NP (DT a) (QP (QP (RB nearly) (CD 3)) (HYPH -) (JJ fold)) (NN increase)) (PP (IN in) (NP (NP (NML (NML (NN blood) (PRN (-LRB- -LRB-) (NP (NN Figure) (NN 2B)) (-RRB- -RRB-))) (CC and) (NML (NN urine) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-)))) (NNS levels)) (PP (IN of) (NP (NN BCAA) (PRN (-LRB- -LRB-) (NP (NP (NN sum)) (PP (IN of) (NP (NN leucine) (, ,) (NN isoleucine) (, ,) (CC and) (NN valine)))) (-RRB- -RRB-)))))) (PP (IN as) (PP (VBN compared) (PP (IN to) (NP (PRP$ their) (NML (SYM +) (HYPH /) (SYM +)) (NNS littermates))))))) (. .)) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-1 (NN amino) (NNS acids)) (VP (VBD were) (VP (VBN analyzed) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NN tandem) (NN mass) (NN spectrometry))))))) (, ,) (NP-SBJ (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NN BCAA)))) (VP (VBN shown) (NP (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2B))))) (ADVP (RB also)) (VP (MD may) (VP (VB include) (NP (NP (NN alloisoleucine)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (MD may) (VP (VB have) (VP (VBN been) (VP (VBN produced) (NP-2 (-NONE- *)) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NN MSUD) (NNS mice)))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NN metabolism)) (PP (IN of) (NP (NN BCAA)))) (VP (VBZ is) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (DT the) (NN synthesis)) (PP (IN of) (NP (NN alanine) (, ,) (NN glutamate) (, ,) (CC and) (NN glutamine))))) (PRN (-LRB- [) (NP (CD 33)) (-RRB- ])))) (. .)) )
( (S (UCP-PRP (PP (IN Because) (IN of) (NP (NP (JJ impaired) (NN metabolism)) (PP (IN of) (NP (NN BCAA))) (PP-LOC (IN in) (NP (NN MSUD) (NNS mice))))) (, ,) (CC and) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB further)) (VP (VB characterize) (NP (DT the) (JJ abnormal) (NN biochemistry)) (PP-LOC (IN in) (NP (DT this) (NN model))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD analyzed) (NP (NP (DT the) (NN blood) (NNS levels)) (PP (IN of) (NP (DT the) (NML (NN alanine) (, ,) (NN glutamate) (, ,) (CC and) (NN glutamine)))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Table) (CD 1)))))) (, ,) (NP-SBJ (NP (DT the) (NNS levels)) (PP (IN of) (NP (DT all) (CD three) (NN amino) (NNS acids))) (PP-LOC (IN in) (NP (JJ homozygous) (NNS mice)))) (VP (VBD were) (ADJP-PRD (ADJP (RB markedly) (JJR lower)) (PP (IN than) (NP (NP (DT the) (NNS levels)) (PP (IN in) (NP (NML (NML (SYM +) (HYPH /) (SYM +)) (CC or) (NML (SYM +) (HYPH /) (SYM -))) (NNS mice))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS levels)) (PP (IN of) (NP (DT these) (NN amino) (NNS acids))) (PP-LOC (IN in) (NP (DT the) (NML (SYM +) (HYPH /) (SYM -)) (NNS mice)))) (VP (VBD were) (ADJP-PRD (JJ comparable) (PP (IN to) (NP (NP (DT those)) (PP-LOC (IN in) (NP (NML (SYM +) (HYPH /) (SYM +)) (NNS mice)))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (NP (NP (DT the) (JJ abnormal) (NN decrease)) (PP (IN in) (NP (DT the) (NN blood) (NN alanine) (NN level)))) (CC and) (NP (NP (JJ marked) (NN rise)) (PP (IN in) (NP (NN blood) (NN BCAA) (NNS levels))))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADJP-PRD (JJ characteristic) (PP (IN of) (NP (NN MSUD))))))))) (, ,) (NP-SBJ (NP (DT a) (JJ recent) (NN report)) (PP (IN on) (NP (NN MSUD) (NNS patients)))) (VP (VBZ has) (VP (VBN suggested) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NN ratio)) (PP (IN of) (NP (NN BCAA) (HYPH /) (NN alanine)))) (VP (VBZ provides) (NP (NP (DT a) (ADJP (RBR more) (JJ sensitive)) (NN measure)) (PP (IN of) (NP (NP (DT the) (JJ abnormal) (NN biochemistry)) (PP (IN of) (NP (NN MSUD))))) (PP (IN than) (NP (NP (NN BCAA) (NN level)) (ADVP (RB alone)))))))) (PRN (-LRB- [) (NP (CD 8)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Therefore)) (, ,) (NP-SBJ (PRP we)) (ADVP (RB also)) (VP (VBD expressed) (NP (DT the) (NML (NN amino) (NN acid)) (NNS results)) (PP-MNR (IN as) (NP (NML (NN BCAA) (HYPH /) (NN alanine)) (NN ratio)))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NN 2C)))))) (, ,) (NP-SBJ (NP (DT this) (NN ratio)) (PP-LOC (IN in) (NP (NML (SYM -) (HYPH /) (SYM -)) (NNS pups)))) (VP (VBD was) (ADJP-PRD (ADJP (QP (QP (RBR more) (IN than) (CD 6)) (HYPH -) (RB fold)) (JJR higher)) (PP (IN than) (NP (NML (NML (SYM +) (HYPH /) (SYM +)) (CC or) (NML (SYM +) (HYPH /) (SYM -))) (NNS littermates))))) (. .)) )
( (S (NP-SBJ (DT These) (NN blood) (NML (NN amino) (NN acid)) (NNS results)) (VP (VBP are) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (DT the) (NNS concentrations)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS patients)) (PP (IN with) (NP (NN MSUD))))))))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 8) (, ,) (CD 15)) (-RRB- ]))) (. .)) )
( (HEADING (NP (NN Table) (CD 1))) )
( (CAPTION (NP (NP (NN Summary)) (PP (IN of) (NP (NP (JJ additional) (NN blood) (NML (NN amino) (NN acid)) (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (JJ classic) (NN MSUD) (NN model)) (CC and) (NP (NN control) (NNS littermates)))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ tandem) (NN mass) (NN spectrometry)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT All) (NNS samples)) (VP (VBD were) (VP (VBN collected) (NP-1 (-NONE- *)) (PP-TMP (IN on) (NP (NP (DT the) (NN day)) (PP (IN of) (NP (NN birth))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT All) (NNS values)) (VP (VBP are) (NP-PRD (NN mean) (CONJP (SYM +) (HYPH /) (SYM -)) (NN SEM))) (. .))) )
( (CAPTION (FRAG (NP (SYM *)) (: :) (ADJP (ADJP (RB Significantly) (JJ different)) (PP (IN from) (NP (NP (SYM +) (HYPH /) (SYM +)) (CC and) (NP (SYM +) (HYPH /) (SYM -))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.001)))) (-RRB- -RRB-)))) (. .))) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (NN E2) (NN knockout) (NNS mice)) (VP (VP (VBP lack) (NP (NP (NN BCKDH) (JJ enzymatic) (NN activity)) (, ,) (NP (NN E2) (NN immunoreactivity)))) (, ,) (CC and) (VP (VBP have) (NP (NP (ADJP (RB markedly) (VBN elevated)) (NNS levels)) (PP (IN of) (NP (NN BCAA)))) (PP-LOC (IN in) (NP (DT the) (NML (NN blood) (CC and) (NN urine)))))) (. .)) )
( (S (NP-SBJ (DT These) (JJ metabolic) (NNS derangements)) (ADVP (RB ultimately)) (VP (VBP result) (PP (IN in) (NP (JJ neonatal) (NN lethality)))) (. .)) )
( (S (NP-SBJ (DT These) (NNS phenotypes)) (VP (VBP are) (ADJP-PRD (RB remarkably) (JJ similar) (PP (IN to) (NP (NP (DT that)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NNS humans)) (PP (IN with) (NP (NP (DT the) (JJ classic) (NN form)) (PP (IN of) (NP (NN MSUD)))))))))))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (NN E2) (NN knockout) (NNS mice)) (ADVP (RB closely)) (VP (VBP model) (NP (JJ classic) (NN MSUD))) (. .)) )
( (HEADING (S (NP-SBJ (NP (NN Knockout) (NNS mice)) (VP (VBG expressing) (NP (DT a) (JJ human) (NN E2) (NN transgene)))) (VP (VBP model) (NP (NP (NP (DT a) (JJ variant) (NN form)) (PP (IN of) (NP (NN MSUD)))) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ mimics) (NP (JJ intermediate) (NN MSUD))))))))) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB create) (NP (NP (DT a) (JJ murine) (NN model)) (PP (IN of) (NP (NP (DT the) (JJ intermediate) (NN variant) (NN form)) (PP (IN of) (NP (NN MSUD))))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (DT a) (JJ transgenic) (NN strategy)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB rescue) (NP (NP (NP (DT the) (JJ severe) (NN elevation)) (PP (IN of) (NP (NN BCAA)))) (CC and) (NP (NP (JJ neonatal) (NN lethality)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBZ occurs) (PP (IN in) (NP (DT the) (JJ classic) (NN MSUD) (NN mouse) (NN model)))))))))))) (. .)) )
( (S (NP-SBJ-1 (PRP$ Our) (NN strategy)) (VP (VBD was) (VP (VBN composed) (NP-1 (-NONE- *)) (PP (IN of) (NP (NP (DT a) (NML (CD two) (NN part)) (JJ transgenic) (NN system)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB express) (NP (JJ human) (NN E2)) (PP-LOC (IN in) (NP (NN liver))) (PP (IN on) (NP (DT the) (NML (NN E2) (NN knockout)) (NN background))))))))))) (. .)) )
( (S (NP-SBJ (DT This) (JJ bi-transgenic) (NN system)) (VP (VBD consisted) (PP (IN of) (NP (NP (DT a) (NML (NN LAP) (HYPH -) (NN tTA)) (NN transgene)) (CC and) (NP (DT a) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene)))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 3A)) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (NML (NN LAP) (HYPH -) (NN tTA)) (NN transgene) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ]))) (VP (VBZ directs) (NP (NP (JJ high) (NNS levels)) (PP (IN of) (NP (NP (ADJP (NN liver) (JJ specific)) (NN expression)) (PP (IN of) (NP (NP (DT the) (NML (NML (ADJP (NN tetracycline) (HYPH -) (VBN controlled)) (NN transactivator)) (-LRB- -LRB-) (NML (NN tTA)))) (-RRB- -RRB-) (, ,) (NP (NP (DT a) (NN transcription) (NN factor)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ stimulates) (NP (NP (NN expression)) (PP (IN of) (NP (NP (NNS promoters)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBP harbor) (NP (DT a) (NML (NML (NN transactivator) (NN response) (NN element)) (-LRB- -LRB-) (NML (NN TRE)))))))))))))))))))) (-RRB- -RRB-) (. .)) )
( (S (NP-SBJ-1 (DT The) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene)) (VP (VBD was) (VP (VBN designed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB express) (NP (DT a) (JJ human) (NN E2) (NN cDNA)) (PP (IN from) (NP (NP (DT a) (NN TRE)) (VP (VBG containing) (NP (JJ minimal) (NN promoter))))) (PP-TMP (IN upon) (NP (NP (NN stimulation)) (PP (IN by) (NP (NN tTA)))))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 3))) )
( (HEADING (NP (JJ Transgenic) (NN mouse) (NML (NN production) (CC and) (NN characterization)) (. .))) )
( (CAPTION (NP (LST (LS A)) (, ,) (NP (JJ Transgenic) (NN strategy)) (VP (VBN used) (NP (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NP (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP express) (NP (JJ human) (NN E2)))))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NML (NN LAP) (HYPH -) (NN tTA)) (JJ transgenic) (NNS mice)) (VP (VBP have) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ])))) (. .))) )
( (CAPTION (S (NP-SBJ (DT These) (NNS mice)) (VP (VBP express) (NP (NP (DT the) (NML (NML (ADJP (NN tetracycline) (HYPH -) (VBN controlled)) (NN transactivator)) (-LRB- -LRB-) (NML (NN tTA)))) (-RRB- -RRB-) (PP (IN from) (NP (DT the) (ADJP (NN liver) (JJ specific)) (NN LAP) (NN promoter))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT The) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene)) (VP (VBZ contains) (NP (NP (NP (DT the) (NML (NML (NN tetracycline) (NN response) (NN element)) (-LRB- -LRB-) (NML (NN TRE)))) (-RRB- -RRB-) (PP (IN as) (NP (NP (NN part)) (PP (IN of) (NP (DT the) (NN promoter)))))) (, ,) (NP (DT a) (JJ synthetic) (NN intron) (PRN (-LRB- -LRB-) (NP (JJ thin) (NN line)) (-RRB- -RRB-))) (, ,) (NP (DT the) (JJ human) (NN E2) (NN cDNA)) (, ,) (NP (DT an) (NN alanine) (NN spacer)) (, ,) (NP (DT a) (NML (NN c) (HYPH -) (NN myc)) (NN epitope) (NN tag)) (, ,) (CC and) (NP (ADJP (NN SV40) (VBN derived)) (NN polyadenylation) (NN sequence)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT This) (NN construct)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (JJ several) (NNS lines)) (PP (IN of) (NP (JJ transgenic) (NNS mice))))))))) (. .))) )
( (CAPTION (NP (LST (LS B)) (, ,) (NP (NML (NNP Western) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NN E2) (NN protein)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN of) (NP (NML (NN control) (CC and) (JJ intermediate)) (NN MSUD) (NNS mice))))))) (. .))) )
( (CAPTION (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (S (NP-SBJ (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ human) (NN E2) (NN protein) (PRN (-LRB- -LRB-) (NP (NP (VBN predicted) (NN MW)) (NP (QP (SYM ~) (CD 54)) (NN Kd))) (-RRB- -RRB-)))) (PP-LOC (IN in) (NP (NP (NNS mice)) (PP (IN from) (NP (NNS Lines) (NML (NML (NN A)) (CC and) (NML (CD 525) (NN A)))))))) (VP (VBD was) (ADJP-PRD (JJ variable)))) (CC but) (S (PP-LOC (IN in) (NP (NP (JJ many)) (PP (IN of) (NP (DT the) (NNS animals))))) (NP-SBJ (DT the) (NN amount)) (VP (VBD was) (ADJP-PRD (JJ similar) (PP (IN to) (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN mouse) (NN E2) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN MW)) (VP (SYM =) (NP (QP (SYM ~) (CD 47)) (NN Kd)))) (-RRB- -RRB-)))) (PP-LOC (IN in) (NP (NN control) (NNS animals))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NN Re) (HYPH -) (NN probing)) (PP (IN with) (NP (DT a) (NML (NN c) (HYPH -) (NN myc)) (NN tag) (NN antibody)))) (VP (VBD confirmed) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (DT the) (ADJP (NN transgene) (VBN derived)) (, ,) (ADJP (NP (NN c) (HYPH -) (NN myc)) (VBN tagged)) (, ,) (JJ human) (NN E2)))) (PP-LOC (PP (IN in) (NP (JJ transgenic) (NNS mice))) (CONJP (CC but) (RB not)) (PP (IN in) (NP (NNS controls))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (NML (NNP Western) (NN blot)) (NN analysis)) (PP (IN of) (NP (NP (NN brain) (PRN (-LRB- -LRB-) (NP (NN C)) (-RRB- -RRB-))) (, ,) (NP (NN kidney) (PRN (-LRB- -LRB-) (NP (NN D)) (-RRB- -RRB-))) (, ,) (CC and) (NP (NN muscle) (PRN (-LRB- -LRB-) (NP (NN E)) (-RRB- -RRB-)))))) (VP (VBD revealed) (NP (NP (JJ negligible) (NNS amounts)) (PP (IN of) (NP (ADJP (NN transgene) (VBN derived)) (NN E2)))) (PP-LOC (IN in) (NP (DT those) (NNS tissues)))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (DT All) (NNS blots)) (VP (VBD were) (VP (VBN re-probed) (NP-1 (-NONE- *)) (PP-MNR (IN with) (NP (DT an) (NN actin) (NN antibody))) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB allow) (S (NP-SBJ-2 (NP (NN amount)) (PP (IN of) (NP (NP (NN protein)) (VP (VBN loaded) (NP (-NONE- *)) (PP (IN in) (NP (DT each) (NN lane))))))) (VP (TO to) (VP (VB be) (VP (VBN compared) (NP-2 (-NONE- *))))))))))) (. .))) )
( (S (NP-SBJ-1 (NML (NN LAP) (HYPH -) (NN tTA)) (NNS mice)) (VP (VBD were) (ADVP-TMP (RB previously)) (VP (VBN produced) (CC and) (VBN characterized) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NNP Bujard) (NN laboratory))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ-1 (JJ Pronuclear) (NN microinjection)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB produce) (NP (NP (JJ transgenic) (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD harbored) (NP (DT the) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene))))))))))) (. .)) )
( (S (PP (IN From) (NP (NP (NNS injections)) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Pittsburgh))))))) (, ,) (NP-SBJ-1 (NP (CD 2) (ADJP (NN transgene) (JJ positive)) (NNS founders)) (SBAR-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN identified) (NP-1 (-NONE- *)) (SBAR-2 (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBD led) (PP (IN to) (NP (NP (DT the) (NN generation)) (PP (IN of) (NP (CD 3) (JJ different) (JJ transgenic) (NNS lines) (PRN (-LRB- -LRB-) (NP (NNS Lines) (NML (NN A) (, ,) (NN B) (, ,) (CC &) (NN D))) (-RRB- -RRB-))))))))))) (. .)) )
( (S (PP (IN From) (NP (NP (DT the) (NNS injections)) (PP (IN at) (NP (NP (DT the) (NNP University)) (PP (IN of) (NP (NNP Cincinnati))))))) (, ,) (NP-SBJ (PRP we)) (VP (VBD obtained) (NP (CD 8) (ADJP (NN transgene) (JJ positive)) (NNS founders))) (. .)) )
( (S (NP-SBJ (NP (JJ Subsequent) (NN breeding)) (PP (IN of) (NP (DT these) (NNS founders)))) (VP (VBD revealed) (SBAR (IN that) (S (NP-SBJ (NP (JJ many)) (PP (IN of) (NP (DT the) (NNS animals)))) (VP (VBD had) (NP (NP (JJ multiple) (NN transgene) (NN insertion) (NNS sites)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD segregated))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBD established) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (CD 15) (JJ different) (JJ transgenic) (NNS lines)))) (PP (IN from) (NP (DT these) (NNS founders)))) (. .)) )
( (S (NP-SBJ (VBN Limited) (NNS resources)) (VP (VBD allowed) (S (NP-SBJ (PRP us)) (VP (TO to) (ADVP (RB only)) (VP (VB focus) (PP (IN on) (NP (NP (DT a) (NN total)) (PP (IN of) (NP (NP (CD 9)) (PP (IN of) (NP (DT these) (NNS lines))))))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS lines)) (VP (VBD differed) (ADVP (RB substantially)) (PP-MNR (IN in) (NP (NN transgene) (NN copy) (NN number))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN compared) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NML (NNP Southern) (NN blot)) (NN analysis)) (PP (IN of) (NP (NN tail) (NN DNA)))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-2 (NNS data)) (RB not) (VP (VBN shown) (NP-2 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ-2 (NP (JJ Transgenic) (NML (NN TRE) (HYPH -) (NN E2)) (NNS mice)) (PP (IN from) (NP (DT each) (NN line) (PRN (-LRB- -LRB-) (NP (CC either) (NML (NNS founders) (CC or) (NN F1)) (NN offspring)) (-RRB- -RRB-))))) (VP (VBD were) (VP (VBN crossed) (NP-2 (-NONE- *)) (PP (IN to) (NP (NP (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VP (VBD were) (ADJP-PRD (JJ positive) (PP (IN for) (NP (DT the) (NML (NN LAP) (HYPH -) (NN tTA)) (NN transgene))))) (CC and) (VP (VBD were) (ADJP-PRD (JJ heterozygous) (PP (IN for) (NP (DT the) (NN E2) (NN knockout)))))))))))) (. .)) )
( (S (ADVP (RB Ultimately)) (, ,) (NP-SBJ-1 (NP (VBG breeding) (NNS pairs)) (SBAR-2 (-NONE- *ICH*))) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (SBAR-2 (WHPP-3 (IN in) (WHNP (WDT which))) (S (NP-SBJ (DT the) (NNS mice)) (VP (VBD were) (ADJP-PRD (JJ heterozygous) (PP (IN for) (NP (NP (DT the) (NML (NN LAP) (HYPH -) (NN tTA)) (NN transgene)) (, ,) (NP (DT the) (NML (NN TRE) (HYPH -) (NN E2)) (NN transgene)) (, ,) (CC and) (NP (DT the) (NN E2) (NN knockout))))) (PP-3 (-NONE- *T*))))))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (ADVP (RB efficiently)) (VP (VB screen) (PP (IN for) (NP (NP (DT the) (NN ability) (S-2 (-NONE- *ICH*))) (PP (IN of) (NP (DT the) (NNS transgenes))) (S-2 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB rescue) (NP (DT the) (NN knockout)) (PP (IN from) (NP (JJ neonatal) (NN lethality))))))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD genotyped) (NP (NNS litters)) (PP-TMP (IN at) (NP (NN weaning)))) (. .)) )
( (S (NP-SBJ-1 (DT This) (VBG breeding) (NN strategy)) (VP (VBZ is) (VP (VBN expected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB result) (PP (IN in) (NP (NP (DT a) (JJ theoretical) (NN maximum)) (PP (IN of) (NP (NP (NNS animals)) (PP (IN with) (NP (DT the) (NN rescue) (NN genotype) (PRN (-LRB- -LRB-) (UCP (ADVP (FW i.e.)) (, ,) (NP (JJ homozygous) (NN E2) (NN knockout)) (CC and) (ADJP (JJ positive) (PP (IN for) (NP (DT both) (NNS transgenes))))) (-RRB- -RRB-)))))) (PP (IN of) (NP (CD 14) (NN %)))))))))) (. .)) )
( (S (NP-SBJ (NN Fig.) (NN 4A)) (VP (VBZ shows) (NP (NP (DT the) (NN percentage)) (PP (IN of) (NP (NP (NNS mice)) (ADJP (JJ alive) (PP-TMP (IN at) (NP (NN weaning)))))) (PP (IN with) (NP (NP (DT the) (NN rescue) (NN genotype)) (PP (IN from) (NP (NP (DT each) (JJ transgenic) (NN line)) (VP (VBN tested) (NP (-NONE- *))))))))) (. .)) )
( (S (NP-SBJ-1 (JJ Considerable) (NN variability)) (VP (VBD was) (VP (VBN observed) (NP-1 (-NONE- *)) (PP (IN between) (NP (NNS lines))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN line)) (PP (IN with) (NP (NP (DT the) (JJS highest) (NN percentage)) (PP (IN of) (NP (NN rescue) (NNS mice))) (PP-TMP (IN at) (NP (NN weaning)))))) (VP (VBD was) (NP-PRD (NN line) (CD 525) (NN A))) (. .)) )
( (S (NP-SBJ (NP (QP (RB Approximately) (CD 10)) (NN %)) (PP (IN of) (NP (VBN weaned) (, ,) (VBG surviving) (NNS pups))) (PP (IN from) (NP (DT this) (NN line)))) (VP (VBD had) (NP (DT the) (NN rescue) (NN genotype))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ-1 (DT the) (NN 525A) (NN transgene)) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (RB highly) (JJ effective) (PP (IN at) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG rescuing) (NP (NP (DT the) (JJ neonatal) (JJ lethal) (NN phenotype)) (PP (IN of) (NP (DT the) (NN E2) (NN knockout)))))))))))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ-1 (NN line) (NN 520B)) (ADVP (RB completely)) (VP (VBD failed) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB rescue) (NP (DT the) (JJ neonatal) (JJ lethal) (NN phenotype)))))) (. .)) )
( (S (NP-SBJ (NP (DT All) (JJ other) (NNS lines)) (VP (VBN tested) (NP (-NONE- *)))) (VP (VBD produced) (NP (VBG surviving) (NN rescue) (NNS animals)) (PP-TMP (IN at) (NP (NP (DT a) (NN frequency)) (PP (IN between) (NP (NP (QP (CD 1) (CC and) (CD 5)) (NN %)) (PP (IN of) (NP (VBN weaned) (NNS pups)))))))) (. .)) )
( (HEADING (NP (NN Figure) (CD 4))) )
( (CAPTION (NP (NP (NN Characterization)) (PP (IN of) (NP (DT the) (JJ intermediate) (NN MSUD) (JJ murine) (NN model))) (. .))) )
( (CAPTION (NP (LST (LS A)) (, ,) (NP (NP (NN Survival) (NN analysis)) (PP (IN of) (NP (JJ transgenic) (NN rescue) (NNS lines)))) (. .))) )
( (CAPTION (SINV (VP-TPC-1 (VBN Presented) (NP-4 (-NONE- *))) (VP (VBP are) (VP-1 (-NONE- *T*))) (NP-SBJ-4 (NP (NNS percentages)) (PP (IN of) (NP (NP (NP (NNS mice)) (ADJP (JJ alive) (PP-TMP (IN at) (NP (VBG weaning))))) (PP (IN from) (NP (NP (NP (DT each) (JJ transgenic) (NN line)) (SBAR-3 (-NONE- *ICH*))) (VP (VBN tested) (NP (-NONE- *)) (SBAR-3 (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD had) (NP (DT the) (NN rescue) (NN genotype)) (PRN (-LRB- -LRB-) (ADJP (ADVP (FW i.e.)) (, ,) (ADJP (JJ homozygous) (PP (IN for) (NP (NP (NN knockout)) (PP (IN of) (NP (JJ endogenous) (NN E2)))))) (CC and) (ADJP (JJ positive) (PP (IN for) (NP (CC both) (DT the) (NML (NML (NN LAP) (HYPH -) (NN tTA)) (CC and) (NML (NN TRE) (HYPH -) (NN E2))) (NNS transgenes))))) (-RRB- -RRB-))))))))))) (. .))) )
( (CAPTION (SINV (ADVP (RB Also)) (VP-TPC-3 (VBN plotted) (NP-4 (-NONE- *T*))) (VP (VBZ is) (VP-3 (-NONE- *T*))) (NP-SBJ-4 (NP (DT the) (JJ theoretical) (JJ maximum) (NN frequency)) (SBAR (WHPP-2 (IN at) (WHNP (WDT which))) (S (NP-SBJ-1 (DT this) (NN genotype)) (VP (VBZ is) (VP (VBN expected) (NP-1 (-NONE- *)) (PP (IN in) (NP (NP (DT this) (NN population)) (PP (IN of) (NP (NNS animals))))) (PP-TMP-2 (-NONE- *T*))))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS numbers)) (PP (IN on) (NP (DT the) (NNS bars)))) (VP (VBZ indicates) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NNS observations))) (PP (IN for) (NP (DT each) (NN line))))) (. .))) )
( (CAPTION (NP (LST (LS B)) (, ,) (NP (NP (NN Ratio)) (PP (IN of) (NP (JJ total) (NN BCAA))) (PP (IN to) (NP (NN alanine))) (PP-LOC (IN in) (NP (NP (NN blood)) (PP (IN of) (NP (NNS mice))))) (PP (IN from) (NP (NP (NNS controls)) (CC and) (NP (NNS Lines) (NML (NN A) (CC and) (NN 525A)))))) (. .))) )
( (CAPTION (S (NP-SBJ (JJ Total) (NN BCAA)) (VP (VBP represent) (NP (NP (DT the) (NN sum)) (PP (IN of) (NP (NN leucine) (, ,) (NN isoleucine) (, ,) (CC and) (NN valine))))) (. .))) )
( (CAPTION (S (NP-SBJ (NML (NN BCAA) (HYPH /) (NN alanine)) (NNS values)) (VP (VBD were) (ADJP-PRD (ADJP (RB significantly) (JJR greater)) (PP (IN for) (NP (NNS Lines) (NML (NN A) (CC and) (NN 525A)))) (PP (VBN compared) (PP (IN to) (NP (NNS controls))))) (PP-TMP (IN at) (NP (NP (DT all) (NNS ages)) (VP (VBN tested) (NP (-NONE- *)))))) (. .))) )
( (CAPTION (S (NP-SBJ (NP (DT The) (NNS numbers)) (PP (IN on) (NP (DT the) (NNS bars)))) (VP (VBZ indicates) (NP (NP (DT the) (NNS numbers)) (PP (IN of) (NP (NP (NNS samples)) (VP (VBN analyzed) (NP (-NONE- *))))))) (. .))) )
( (CAPTION (S (S-FRM (SYM *) (, ,) (NP-SBJ (NN P)) (VP (SYM ≤) (NP (CD 0.01)))) (: ;) (S-FRM (SYM **) (, ,) (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.005)))) (. .))) )
( (CAPTION (NP (LST (LS C)) (, ,) (NP (NN BCKDH) (NN enzyme) (NN activity)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN of) (NP (NML (NML (NN control)) (CC and) (NML (NNS Lines) (NML (NN A) (CC and) (NN 525A)))) (NNS mice))))) (. .))) )
( (CAPTION (S (S-FRM (SYM *) (, ,) (NP-SBJ (NN P)) (VP (SYM ≤) (NP (CD 0.001)))) (: ;) (S-FRM (SYM **) (, ,) (NP-SBJ (NN P)) (VP (SYM ≤) (NP (CD 0.0001)))) (. .))) )
( (CAPTION (NP (LST (LS D)) (, ,) (NP (NN Survival) (NNS curves)) (PP (IN for) (NP (NP (NNS mice)) (PP (IN from) (NP (NNS Lines) (NML (NN A) (CC and) (NN 525A)))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NP (NN Rescue) (NNS mice)) (ADJP (JJ alive) (PP-TMP (IN at) (NP (NN weaning))))) (VP (VBD were) (VP (VBN monitored) (NP-1 (-NONE- *)) (SBAR-TMP (IN until) (S (NP-SBJ-2 (PRP they)) (VP (VP (VBD were) (UCP-PRD (ADJP (JJ moribund)) (CC and) (VP (ADVP (RB subsequently)) (VBN sacrificed) (NP-2 (-NONE- *))))) (CC or) (VP (VBD were) (VP (VBN found) (NP-2 (-NONE- *)) (S-ADV (NP-SBJ-2 (-NONE- *PRO*)) (ADJP-PRD (JJ dead))) (PP-LOC (IN in) (NP (PRP$ their) (NNS cages)))))))))) (. .))) )
( (S (NP-SBJ-1 (NNS Lines) (NML (NN A) (CC and) (NN 525A))) (VP (VBD were) (VP (VBN selected) (NP-1 (-NONE- *)) (PP (IN for) (NP (VBN detailed) (NN characterization))))) (. .)) )
( (S (NP-SBJ (NN Fig.) (NN 4B)) (VP (VBZ shows) (NP (NP (NP (DT the) (NNS results)) (PP (IN of) (NP (NN blood) (NML (NN amino) (NN acid)) (NN analysis)))) (VP (VBN presented) (NP (-NONE- *)) (PP-MNR (IN as) (NP (NP (DT a) (NN ratio)) (PP (IN of) (NP (JJ total) (NN BCAA))) (PP (IN to) (NP (NN alanine)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT The) (NML (NN BCAA) (HYPH /) (NN alanine)) (NNS values)) (PP (IN for) (NP (NP (NNS mice)) (PP (IN from) (NP (DT both) (NNS lines)))))) (VP (VBD were) (ADJP-PRD (RB significantly) (JJ elevated)) (PP (VBN compared) (PP (IN to) (NP (NP (NNS controls)) (PP (IN for) (NP (NP (DT all)) (PP (IN of) (NP (NP (DT the) (NN time) (NNS points)) (VP (VBN analyzed) (NP (-NONE- *))))))))))) (. .)) )
( (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB Note) (SBAR (IN that) (S (NP-SBJ (NP (DT the) (NML (NN BCAA) (HYPH /) (NN alanine)) (NNS values)) (PP (IN for) (NP (DT the) (JJ transgenic) (NNS mice)))) (VP (VBP are) (ADJP-PRD (JJ intermediate)) (PP (IN between) (NP (NNS controls) (CC and) (NNS knockouts))) (PRN (-LRB- -LRB-) (S-IMP (NP-SBJ (-NONE- *PRO*)) (VP (VB see) (NP (NN Figure) (NN 2C)))) (-RRB- -RRB-)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Blood) (NNS levels)) (PP (IN of) (NP (NN alanine) (, ,) (NN glutamate) (, ,) (CC and) (NN glutamine)))) (VP (VBD were) (VP (VBN reduced) (NP-1 (-NONE- *)) (PP-LOC (IN in) (NP (NML (NN Line) (NN A)) (NNS mice))) (, ,) (SBAR-ADV (IN as) (SINV (VBD was) (VP (-NONE- *?*)) (NP-SBJ (NP (NN glutamate)) (PP-LOC (IN in) (NP (NML (NN Line) (NN 525A)) (NNS mice))) (, ,) (PP (VBN compared) (PP (IN to) (NP (NNS controls))))) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 2)) (-RRB- -RRB-)))))) (. .)) )
( (HEADING (NP (NN Table) (CD 2))) )
( (CAPTION (NP (NP (NN Summary)) (PP (IN of) (NP (NP (NP (JJ additional) (NN blood) (NML (NN amino) (NN acid)) (NNS levels)) (PP-LOC (IN in) (NP (NP (DT the) (JJ intermediate) (NN MSUD) (NN model)) (CC and) (NP (NN littermate) (NNS controls))))) (SBAR (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN determined) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (JJ tandem) (NN mass) (NN spectrometry)))))))) (. .))) )
( (CAPTION (S (NP-SBJ-1 (NNS Samples)) (VP (VBD were) (VP (VBN collected) (NP-1 (-NONE- *)) (PP (IN from) (NP (NP (NNS mice)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VBD were) (NP-PRD (NP (QP (CD 4) (SYM –) (CD 6)) (NNS weeks)) (PP (IN of) (NP (NN age))))))))))) (. .))) )
( (CAPTION (S (NP-SBJ (DT All) (NNS values)) (VP (VBP are) (NP-PRD (NN mean) (CONJP (SYM +) (HYPH /) (SYM -)) (NN SEM))) (. .))) )
( (CAPTION (FRAG (NP (SYM *)) (: :) (ADJP (RB Significantly) (JJ different) (PP (IN from) (NP (NN control))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (FRAG (NP (SYM **)) (: :) (ADJP (RB Significantly) (JJ different) (PP (IN from) (NP (NN control))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.01)))) (-RRB- -RRB-))) (. .))) )
( (CAPTION (FRAG (NP (SYM ***)) (: :) (ADJP (RB Significantly) (JJ different) (PP (IN from) (NP (NN Line) (NN 525A))) (PRN (-LRB- -LRB-) (S-FRM (NP-SBJ (NN P)) (VP (SYM <) (NP (CD 0.05)))) (-RRB- -RRB-))) (. .))) )
( (S (SBAR-PRP (IN Because) (S (NP-SBJ-2 (NP (DT the) (NML (NN LAP) (HYPH -) (NN tTA)) (NNS mice)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB drive) (NP (NP (NN expression)) (PP (IN of) (NP (JJ transgenic) (JJ human) (NN E2)))))))))))) (VP (VBP have) (VP (VBN been) (VP (VBN demonstrated) (S (NP-SBJ-2 (-NONE- *)) (VP (TO to) (VP (VB produce) (NP (ADJP (NN liver) (JJ specific)) (NN expression))))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ]))))))) (, ,) (NP-SBJ-3 (NP (NP (NN BCKDH) (NN enzyme) (NN activity)) (CC and) (NP (NP (NN production)) (PP (IN of) (NP (JJ human) (NN E2) (NN protein))))) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN of) (NP (NNS Lines) (NML (NN A) (CC and) (NN 525A))))))) (VP (VBD was) (VP (VBN examined) (NP-3 (-NONE- *)))) (. .)) )
( (S (NP-SBJ (NP (NN BCKDH) (JJ enzymatic) (NN activity)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN from) (NP (NNS Lines) (NML (NN A) (CC and) (NN 525A))))))) (VP (VBD was) (NP-PRD (NP (QP (SYM ~) (CD 6) (CC and) (CD 5)) (NN %)) (PP-1 (-NONE- *ICH*))) (, ,) (ADVP (RB respectively)) (, ,) (PP-1 (IN of) (NP (NP (DT the) (JJ enzymatic) (NN activity)) (ADJP (JJ present) (PP (IN in) (NP (NN control) (NN liver)))))) (PRN (-LRB- -LRB-) (NP (NN Fig.) (NN 4C)) (-RRB- -RRB-))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NNP Fig.) (NN 3B)))))) (, ,) (NP-SBJ (NP (DT the) (NN amount)) (PP (IN of) (NP (JJ human) (NN E2) (PRN (-LRB- -LRB-) (S (NP-SBJ (VBN predicted) (NN MW)) (NP-PRD (QP (SYM ~) (NN 54)) (NN Kd))) (-RRB- -RRB-)))) (PP-LOC (IN in) (NP (DT these) (JJ transgenic) (NNS mice)))) (VP (VBD was) (ADJP-PRD (RB quite) (JJ variable) (PP (IN between) (NP (NNS mice))))) (. .)) )
( (S (PP-LOC (IN In) (NP (NP (DT some)) (PP (IN of) (NP (DT these) (JJ transgenic) (NNS mice))))) (, ,) (NP-SBJ (NP (DT the) (NN level)) (PP (IN of) (NP (JJ human) (NN E2)))) (VP (VBD was) (ADJP-PRD (RB approximately) (JJ equal) (PP (IN to) (NP (NP (NP (DT the) (NN amount)) (PP (IN of) (NP (NN mouse) (NN E2) (PRN (-LRB- -LRB-) (NP (QP (SYM ~) (CD 47)) (NN Kd)) (-RRB- -RRB-))))) (VP (VBN produced) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN liver)) (PP (IN of) (NP (JJ nontransgenic) (NN control) (NNS mice)))))))))) (. .)) )
( (S (NP-SBJ (DT The) (NNS observations) (SBAR (IN that) (S (NP-SBJ (NP (DT these) (ADJP (RB near) (JJ normal)) (NNS amounts)) (PP (IN of) (NP (NN E2) (NN protein)))) (VP (VBP result) (PP (IN in) (NP (NP (QP (RB only) (SYM ~) (CD 5) (SYM –) (CD 6)) (NN %)) (PP (IN of) (NP (JJ normal) (NN BCKDH) (NN enzyme) (NN activity))))))))) (VP (VBP suggest) (SBAR (IN that) (S (NP-SBJ (NN transgene) (VBN derived) (NN E2)) (VP (VBZ is) (VP (VBG functioning) (PP-MNR (IN at) (NP (DT a) (JJ suboptimal) (NN level)))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ probable)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NML (NN c) (HYPH -) (NN myc)) (NN tag)) (PP-LOC (IN at) (NP (NP (DT the) (NN carboxy) (NN terminus)) (PP (IN of) (NP (DT the) (ADJP (NN transgene) (VBN derived)) (JJ human) (NN E2)))))) (VP (VBD interfered) (PP (IN with) (NP (JJ enzymatic) (NN activity))))))) (. .)) )
( (S (NP-SBJ (DT This) (NN interpretation)) (VP (VBZ is) (ADJP-PRD (JJ consistent) (PP (IN with) (NP (NP (JJ previous) (NNS studies)) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP have) (VP (VBN revealed) (SBAR (IN that) (S (S (NP-SBJ (NP (DT the) (NN carboxy) (NN terminus)) (PP (IN of) (NP (NP (DT an) (JJ analogous) (NN subunit)) (PP (IN of) (NP (DT the) (NN pyruvate) (NN dehydrogenase) (NN complex)))))) (VP (VBZ is) (ADJP-PRD (JJ essential) (PP (IN for) (NP (NN subunit) (NNS interactions)))) (PRN (-LRB- [) (NP (CD 35)) (-RRB- ])))) (CC and) (S (NP-SBJ (NP (NN insertion)) (PP (IN of) (NP (DT a) (NN Hisx6) (NN tag))) (PP-LOC (IN on) (NP (NP (DT the) (NN carboxy) (NN terminus)) (PP (IN of) (NP (DT an) (JJ analogous) (NML (FW E.) (FW coli)) (NN subunit)))))) (VP (VBD interfered) (PP (IN with) (NP (JJ normal) (NN subunit) (NN assembly))) (PRN (-LRB- [) (NP (CD 36)) (-RRB- ])))))))))))))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADVP (RB also)) (ADJP-PRD (JJ possible)) (SBAR-1 (IN that) (S (NP-SBJ (JJ human) (NN E2)) (VP (VBD was) (RB not) (ADJP-PRD (RB fully) (JJ functional)) (SBAR-TMP (WHADVP-3 (WRB when)) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (VBN complexed) (NP-2 (-NONE- *)) (PP (IN with) (NP (NP (NN mouse) (NN E1)) (CC and) (NP (NN E3) (NNS subunits)))) (ADVP-TMP-3 (-NONE- *T*))))))))) (. .)) )
( (S (NP-SBJ (JJ Human) (NN E2)) (VP (VBZ shares) (NP (NP (NML (QP (SYM ~) (CD 88)) (NN %)) (NN identity)) (PP (IN to) (NP (NN mouse) (NN E2)))) (PP-LOC (IN at) (NP (DT the) (NML (NN amino) (NN acid)) (NN level)))) (. .)) )
( (S (NP-SBJ-1 (PRP We)) (ADVP (RB also)) (VP (VBD used) (NP (NML (NNP western) (NN blot)) (NN analysis)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB analyze) (NP (NP (NN expression)) (PP (IN of) (NP (DT the) (NN E2) (NN transgene)))) (PP-LOC (IN in) (NP (NN brain) (, ,) (NN kidney) (CC and) (NN muscle))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN shown) (NP-1 (-NONE- *)) (PP (IN in) (NP (NN Figure) (NML (NN 3C) (, ,) (NN D) (CC and) (NN 3E)))) (ADVP (RB respectively))))) (, ,) (NP-SBJ (NP (NN expression)) (PP (IN of) (NP (NN E2)))) (VP (VBZ is) (ADJP-PRD (JJ negligible)) (PP-LOC (IN in) (NP (DT those) (NNS tissues)))) (. .)) )
( (S (NP-SBJ-2 (NP (NML (JJ Long) (HYPH -) (NN term)) (NN survival)) (PP (IN of) (NP (NP (DT the) (NNS mice)) (PP (IN from) (NP (NP (DT these) (CD two) (JJ transgenic) (NNS lines)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD survived) (PP-TMP (IN beyond) (NP (NN weaning))))))))))) (VP (VBZ is) (VP (VBN plotted) (NP-2 (-NONE- *)) (PP (IN in) (NP (NN Fig.) (NN 4D))))) (. .)) )
( (S (SBAR-ADV (IN Although) (S (NP-SBJ-1 (NP (NN survival) (NNS data)) (PP (IN for) (NP (NN control) (NNS animals)))) (VP (VBD was) (RB not) (VP (VBN collected) (NP-1 (-NONE- *)))))) (, ,) (NP-SBJ (NP (PRP it)) (SBAR-2 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (RB readily) (JJ apparent)) (SBAR-2 (IN that) (S (NP-SBJ-3 (NP (NN survival)) (PP (IN of) (NP (DT the) (NN rescue) (NNS mice)))) (VP (VBD was) (VP (VBN compromised) (NP-3 (-NONE- *))))))) (. .)) )
( (S (PP-TMP (IN By) (NP (CD 16) (NNS weeks))) (, ,) (NP-SBJ-1 (NP (DT all) (NNS mice)) (PP (IN of) (NP (NN Line) (NN A)))) (VP (VP (VBD were) (UCP-PRD (ADJP (JJ moribund)) (CC and) (VP (ADVP (RB humanely)) (VBN sacrificed) (NP-1 (-NONE- *))))) (, ,) (CC or) (VP (VBD were) (VP (VBN found) (NP-1 (-NONE- *)) (S-ADV (NP-SBJ-1 (-NONE- *PRO*)) (ADJP-PRD (JJ dead))) (PP-LOC (IN in) (NP (PRP$ their) (NN cage)))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Survival)) (PP (IN of) (NP (NN Line) (NN 525A)))) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (ADJP-PRD (RB somewhat) (JJR better)))))) (. .)) )
( (S (PP-TMP (IN At) (NP (NP (CD 20) (NNS weeks)) (PP (IN of) (NP (NN age))))) (, ,) (NP-SBJ (NP (QP (SYM ~) (CD 12)) (NN %)) (PP (IN of) (NP (NNS mice) (PRN (-LRB- -LRB-) (NP (NP (CD 2)) (PP (IN of) (NP (CD 16)))) (-RRB- -RRB-))))) (VP (VBD were) (ADVP-TMP (RB still)) (ADJP-PRD (JJ alive))) (. .)) )
( (S (NP-SBJ (DT These) (CD two) (JJ rare) (NNS survivors)) (VP (VBD died) (PP-TMP (IN at) (NP (NP (QP (CD 40) (CC and) (CD 60)) (NNS weeks)) (PP (IN of) (NP (NN age)))))) (. .)) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (S (S (NP-SBJ (DT these) (VBG surviving) (NNS mice)) (VP (VBD had) (NP (NP (NML (NN BCAA) (HYPH /) (NN alanine)) (NNS ratios)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD were) (ADJP-PRD (JJ intermediate) (PP (IN between) (NP (NNS controls) (CC and) (NNS knockouts)))))))))) (CC and) (S (NP-SBJ (PRP they)) (VP (VBD expressed) (NP (NP (QP (SYM ~) (CD 5) (SYM –) (CD 6)) (NN %)) (PP (IN of) (NP (NP (JJ normal) (NN BCKDH) (NN enzyme) (NN activity)) (PP-LOC (IN in) (NP (DT the) (NN liver))))))))) (. .)) )
( (S (NP-SBJ (DT These) (JJ phenotypic) (NNS observations)) (VP (VBP are) (ADJP-PRD (RB remarkably) (JJ similar) (PP (IN to) (NP (NP (DT the) (JJ clinical) (NN phenotype)) (VP (VBN observed) (NP (-NONE- *)) (PP-LOC (IN in) (NP (NP (NN MSUD) (NNS patients)) (PP (IN with) (NP (NP (DT the) (JJ intermediate) (NN form)) (PP (IN of) (NP (DT the) (NN disease))))))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (ADVP (RB Thus)) (, ,) (NP-SBJ (DT these) (NN rescue) (NNS mice)) (VP (VBP represent) (NP (NP (DT a) (ADJP (RB very) (JJ useful)) (NN model)) (PP (IN of) (NP (DT the) (JJ intermediate) (NN MSUD) (NN phenotype))))) (. .)) )
( (HEADING (NP (NN Discussion))) )
( (S (NP-SBJ (NP (DT A) (JJ major) (NN hurdle)) (PP (IN in) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG developing) (NP (NP (JJ new) (NNS treatments)) (PP (IN for) (NP (NN MSUD)))))))) (VP (VBZ has) (VP (VBN been) (NP-PRD (NP (DT the) (NN lack)) (PP (IN of) (NP (NP (DT a) (JJ practical) (, ,) (JJ accurate) (NN animal) (NN model)) (PP (IN of) (NP (DT the) (NN disease)))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN hurdle)) (VP (VBZ has) (ADVP-TMP (RB now)) (VP (VBN been) (VP (VBN overcome) (NP-1 (-NONE- *))))) (. .)) )
( (S (PP (IN In) (NP (DT this) (NN report))) (, ,) (NP-SBJ (PRP we)) (VP (VBP describe) (NP (NP (DT the) (NML (NN development) (CC and) (NN characterization))) (PP (IN of) (NP (NP (CD two) (ADJP (RB genetically) (VBN engineered)) (NN mouse) (NNS models)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (ADVP (RB phenotypically)) (ADJP-PRD (RB very) (JJ similar) (PP (IN to) (NP (NP (NN MSUD) (NNS patients)) (PP (IN with) (NP (NP (DT the) (ADJP (JJ classic) (CC and) (JJ intermediate)) (NNS forms)) (PP (IN of) (NP (DT the) (NN disease))))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (PRP$ Our) (NN model)) (PP (IN of) (NP (JJ classic) (NN MSUD)))) (VP (VBD was) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (NP (NP (NN gene) (NN knockout)) (PP (IN of) (NP (NP (DT the) (NN E2) (NN subunit)) (PP (IN of) (NP (NN BCKDH))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN phenotype)) (PP (IN of) (NP (DT these) (NN knockout) (NNS animals)))) (VP (VBZ is) (ADJP-PRD (RB strikingly) (JJ similar) (PP (IN to) (NP (NP (NNS humans)) (PP (IN with) (NP (JJ classic) (NN MSUD))))))) (. .)) )
( (S (NP-SBJ-1 (NN Knockout) (NNS mice)) (VP (VP (VBD were) (VP (VBN born) (NP-1 (-NONE- *)) (PP-TMP (IN at) (NP (DT the) (VBN expected) (NN frequency))))) (CC and) (VP (VBD appeared) (S (NP-SBJ-1 (-NONE- *)) (ADJP-PRD (JJ normal))) (PP-TMP (IN at) (NP (NN birth))))) (. .)) )
( (S (PP-TMP (PP (IN Within) (NP (NP (DT a) (NN day)) (PP (IN of) (NP (NN birth))))) (CC and) (PP (VBG following) (NP (NN suckling)))) (, ,) (NP-SBJ (NP (NN blood) (NNS levels)) (PP (IN of) (NP (NN BCAA)))) (VP (VBD were) (ADJP-PRD (RB markedly) (JJ elevated))) (. .)) )
( (S (ADVP (RB Concomitantly)) (, ,) (NP-SBJ-2 (NP (NNS levels)) (PP (IN of) (NP (NP (NP (DT the) (NN amino) (NNS acids)) (NP (NN alanine) (, ,) (NN glutamate) (, ,) (CC and) (NN glutamine))) (, ,) (SBAR (WHNP-1 (WP$ whose) (NN synthesis)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBZ is) (VP (VBN linked) (NP-1 (-NONE- *)) (PP (IN with) (NP (NP (JJ normal) (NN metabolism)) (PP (IN of) (NP (NN BCAA)))))))))))) (, ,) (VP (VBD were) (VP (VBN decreased) (NP-2 (-NONE- *)) (PRN (-LRB- -LRB-) (NP (NN Table) (CD 1)) (-RRB- -RRB-)))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN activity)) (PP (IN of) (NP (NN BCKDH))) (PP-LOC (IN in) (NP (NP (NNS livers)) (PP (IN of) (NP (NML (JJ homozygous) (NN knockout)) (NN mouse) (NNS pups)))))) (VP (VBD was) (ADJP-PRD (JJ undetectable)) (, ,) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG accounting) (PP (IN for) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (JJ unmetabolized) (NN BCAA)))))))) (. .)) )
( (S (NP-SBJ (JJ Immunoreactive) (NN E2) (NN protein)) (VP (VBD was) (ADJP-PRD (JJ absent)) (PP-LOC (IN in) (NP (NP (NN liver) (CC and) (NNS fibroblasts)) (PP (IN of) (NP (JJ homozygous) (NNS pups)))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (JJ phenotypic) (NN behavior)) (PP (IN of) (NP (JJ homozygous) (NN mouse) (NNS pups)))) (VP (VBZ resembles) (NP (NP (NNS symptoms)) (VP (VBN seen) (NP (-NONE- *)) (PP-LOC (IN in) (NP (JJ newborn) (JJ classic) (NN MSUD) (NNS patients)))))) (. .)) )
( (S (NP-SBJ (DT These)) (VP (VBP include) (NP (NP (NNS signs)) (PP (IN of) (NP (JJ neurologic) (NN dysfunction))) (PP (JJ such) (IN as) (NP (NP (NNS seizures)) (, ,) (NP (NN stupor)) (, ,) (NP (NN lethargy)) (, ,) (NP (NP (NN loss)) (PP (IN of) (NP (NN motor) (NN activity)))) (, ,) (CC and) (NP (JJ respiratory) (NNS difficulties))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (NP-SBJ (DT These) (JJ neurologic) (NNS symptoms)) (VP (MD may) (VP (VB result) (PP (IN from) (NP (NP (VBN reduced) (NNS levels)) (PP (IN of) (NP (NP (NP (NN glutamate)) (, ,) (NP (NN glutamine)) (, ,) (NP (NN alanine)) (, ,) (CC and) (NP (JJ other) (JJ similar) (JJ neuroactive) (NN amino) (NNS acids))) (, ,) (SBAR (WHNP-1 (WDT which)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBP are) (VP (VBN considered) (S (NP-SBJ-1 (-NONE- *)) (NP-PRD (NP (DT the) (NN culprit)) (PP (IN for) (NP (NN MSUD) (NNS encephalopathies))) (PP-LOC (IN in) (NP (NNS patients))))))))))))) (PRN (-LRB- [) (NP (CD 1) (, ,) (CD 37)) (-RRB- ])))) (. .)) )
( (S (ADVP (RB Finally)) (, ,) (NP-SBJ (NP (RB nearly) (DT all)) (PP (IN of) (NP (DT the) (JJ homozygous) (NNS pups)))) (VP (VBD died) (PP-TMP (IN within) (NP (NP (CD 72) (NNS hours)) (PP (IN of) (NP (NN birth)))))) (. .)) )
( (S (NP-SBJ (DT This) (JJ neonatal) (NN lethality)) (VP (VBZ is) (PP-PRD (ADVP (RB likely)) (IN due) (IN to) (NP (NP (DT the) (NN accumulation)) (PP (IN of) (NP (NN BCAA))) (PP (IN to) (NP (NP (JJ neurotoxic) (NNS levels)) (, ,) (NP (NN ketoacidosis)) (, ,) (NP (NN brain) (NN edema)) (, ,) (NP (NN dehydration)) (, ,) (CC and) (NP (NN malnutrition)))))) (SBAR-ADV (IN as) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN observed) (NP-1 (-NONE- *)) (PP-LOC (PP (IN in) (NP (DT the) (NN MSUD) (NN calf) (PRN (-LRB- [) (NP (CD 17)) (-RRB- ])))) (CC and) (PP (IN in) (NP (JJ classic) (NN MSUD) (NNS patients) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))))))))) (. .)) )
( (S (NP-SBJ (JJ Heterozygous) (NNS knockouts)) (VP (VP (VBD were) (ADJP-PRD (JJ normal))) (CC and) (VP (VBD had) (NP (NP (JJ normal) (NNS levels)) (PP (IN of) (NP (NN BCAA)))) (PP (IN despite) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG having) (NP (NP (RB approximately) (NN half)) (PP (IN of) (NP (NN BCKDH) (JJ enzymatic) (NN activity))))))))) (. .)) )
( (S (PP (IN From) (NP (NP (DT the) (NN characterization) (NNS studies)) (VP (VBN completed) (NP (-NONE- *)) (ADVP-TMP (RB thus) (RB far))))) (, ,) (NP-SBJ-1 (DT the) (NML (JJ null) (NN mutation)) (NN mouse)) (VP (VP (ADVP (RB accurately)) (VBZ represents) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ classic) (NN MSUD))))) (CC and) (VP (VBZ appears) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB be) (NP-PRD (NP (DT a) (JJ faithful) (NN model)) (PP (IN of) (NP (DT the) (JJ human) (NN disease)))) (PP-MNR (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (JJ several) (JJ biochemical) (NNS phenotypes)))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ])))) (. .)) )
( (S (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO To) (VP (VB create) (NP (NP (DT a) (NN model)) (PP (IN of) (NP (JJ intermediate) (NN MSUD))))))) (, ,) (NP-SBJ-1 (PRP we)) (VP (VBD used) (NP (DT a) (JJ transgenic) (NN strategy)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB express) (NP (JJ human) (NN E2)) (PP-LOC (IN in) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (NN E2) (NN knockout) (NNS mice))))))))) (. .)) )
( (S (SBAR-ADV (IN As) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (VBN mentioned) (NP-1 (-NONE- *)) (ADVP (RB above))))) (, ,) (NP-SBJ (NP (NN E2) (NNS knockouts)) (PP (IN without) (NP (ADJP (NN transgene) (VBN derived)) (NN E2)))) (VP (VBP die) (PP-TMP (IN during) (NP (DT the) (ADJP (JJ early) (JJ neonatal)) (NN period)))) (. .)) )
( (S (NP-SBJ (PRP We)) (VP (VBP show) (SBAR (IN that) (S (NP-SBJ-1 (NP (NN expression)) (PP (IN of) (NP (DT a) (JJ human) (NN E2) (NN transgene))) (PP-LOC (IN in) (NP (NP (DT the) (NN liver)) (PP (IN of) (NP (DT these) (NN knockout) (NNS mice)))))) (VP (VBZ is) (ADJP-PRD (JJ able) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB rescue) (NP (DT the) (JJ neonatal) (NN lethality)))))))))) (. .)) )
( (S (NP-SBJ (NP (JJ Many)) (PP (IN of) (NP (DT the) (NN rescue) (NNS mice)))) (VP (VBD survived) (PP-TMP (IN to) (NP (NN adulthood)))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (S-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ interesting)) (S-1 (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB note) (SBAR (IN that) (S (PP-LOC (IN in) (NP (DT these) (NN mouse) (NNS lines))) (NP-SBJ-2 (NP (QP (RB only) (SYM ~) (CD 5) (SYM –) (CD 6)) (NN %)) (PP (IN of) (NP (NP (JJ normal) (NN BCKDH) (NN activity)) (PP-LOC (IN in) (NP (DT the) (NN liver)))))) (VP (VBD was) (ADJP-PRD (JJ sufficient) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (VP (VB allow) (NP (NN survival))))))))))))) (. .)) )
( (S (NP-SBJ (PRP We)) (ADVP (RB also)) (VP (VBD demonstrated) (SBAR (IN that) (S (NP-SBJ (NP (NN BCAA) (NNS levels)) (PP-LOC (IN in) (NP (NP (NN blood)) (PP (IN of) (NP (DT these) (NN rescue) (NNS mice)))))) (VP (VBD were) (ADJP-PRD (JJ intermediate)) (PP (IN between) (NP (NNS controls) (CC and) (NNS knockouts))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS hallmarks)) (PP (IN of) (NP (JJ intermediate) (NN MSUD) (JJ human) (NNS patients)))) (VP (VBP are) (NP-PRD (NP (ADJP (RB persistently) (VBN increased)) (NNS levels)) (PP (IN of) (NP (NML (NN BCAA) (CC and) (NN BCKDH)) (NN activity))) (PP (IN in) (NP (NP (DT the) (NN range)) (PP (IN of) (NP (NP (QP (CD 3) (SYM –) (CD 30)) (NN %)) (PP (IN of) (NP (JJ normal)))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (DT the) (JJ phenotypic) (NNS similarities)) (PP (IN of) (NP (DT the) (NN rescue) (NNS mice))) (PP (IN to) (NP (DT the) (JJ human) (NNS patients))))) (, ,) (NP-SBJ (DT these) (ADJP (RB genetically) (VBN engineered)) (NNS mice)) (VP (VBP represent) (NP (NP (DT a) (JJ useful) (NML (JJ small) (NN animal)) (NN model)) (PP (IN of) (NP (NP (DT the) (JJ intermediate) (NN form)) (PP (IN of) (NP (NN MSUD))))))) (. .)) )
( (S (NP-SBJ-2 (NP (DT The) (JJ transgenic) (NN approach)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (VBD was) (VP (VBN used) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (DT the) (JJ intermediate) (NN MSUD) (NN model)))))))))) (VP (VBD was) (VP (VBN based) (NP-2 (-NONE- *)) (PP (IN on) (NP (NP (DT the) (ADJP (NN tetracycline) (VBN regulated)) (NML (NN gene) (NN switch)) (NN system)) (SBAR (WHNP-3 (WDT that)) (S (NP-SBJ-3 (-NONE- *T*)) (VP (VBZ has) (VP (VBN been) (VP (VBN used) (NP-3 (-NONE- *)) (PP (IN with) (NP (JJ great) (NN success))) (PP (IN in) (NP (JJ other) (NNS studies))) (, ,) (PP (IN for) (NP (NN example)))))))))) (PRN (-LRB- [) (NP (CD 34)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN strategy)) (PP (IN behind) (NP (PRP$ our) (NN approach)))) (VP (VBD was) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB create) (NP (NP (NNS mice)) (PP (IN with) (NP (NP (DT an) (JJ intermediate) (NN MSUD) (NN phenotype)) (SBAR (WHNP-1 (WDT that)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (MD could) (VP (VB be) (VP (VBN converted) (NP-1 (-NONE- *)) (PP (IN to) (NP (DT the) (JJ classic) (NN phenotype))) (PP (IN at) (NP (NP (DT the) (NN investigator) (POS 's)) (NN discretion))) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG turning) (PRT (RP off)) (NP (DT the) (VBG rescuing) (NN transgene))))))))))))))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (NP-SBJ-2 (PRP we)) (VP (VBD were) (ADJP-PRD (JJ unable) (S (NP-SBJ-2 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB consistently)) (VP (VB turn) (PRT (RP off)) (NP (DT the) (JJ human) (NN E2) (NN expression) (NN cassette)) (PP-MNR (IN by) (NP (NP (DT the) (JJ potent) (NN tetracycline) (NN analogue)) (, ,) (NP (NN doxycycline)))) (PP-LOC (IN in) (NP (NP (DT either)) (PP (IN of) (NP (NP (DT the) (CD two) (JJ transgenic) (NNS lines)) (VP (VBN tested) (NP (-NONE- *))))))))))) (PRN (-LRB- -LRB-) (S (NP-SBJ-1 (NNS data)) (RB not) (VP (VBN shown) (NP-1 (-NONE- *)))) (-RRB- -RRB-))) (. .)) )
( (S (NP-SBJ (DT The) (NN reason) (SBAR (-NONE- *0*) (S (NP-SBJ (DT these) (CD two) (NNS lines)) (VP (VBD were) (ADJP-PRD (JJ unresponsive) (PP (IN to) (NP (NN doxycycline)))))))) (VP (VBZ is) (ADJP-PRD (JJ unknown))) (. .)) )
( (S (NP-SBJ (NP (PRP It)) (SBAR-1 (-NONE- *EXP*))) (VP (VBZ is) (ADJP-PRD (JJ conceivable)) (SBAR-1 (IN that) (S (NP-SBJ (NP (DT the) (NN integration) (NN site)) (PP (IN of) (NP (DT the) (NNS transgenes)))) (VP (VBD was) (RB not) (ADJP-PRD (JJ permissive) (PP (IN for) (NP (VBN regulated) (NN expression)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Screening)) (PP (IN of) (NP (JJ additional) (NNS lines)))) (VP (MD may) (VP (VB be) (VP (VBN needed) (NP-1 (-NONE- *)) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB find) (NP (NP (NNS lines)) (SBAR (WHNP-2 (WDT that)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (VP (VBP allow) (PP (IN for) (NP (NN survival)))) (CC and) (VP (MD can) (ADVP (RB also)) (VP (VB be) (VP (VBN regulated) (NP-2 (-NONE- *))))))))))))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NNS models)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN communication))))) (VP (VBP are) (NP-PRD (NP (JJ important) (NNS advances)) (PP (IN over) (NP (DT the) (ADJP (RB previously) (VBN described)) (NNS models))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT An) (NN ENU) (NN mouse)) (VP (VBG resembling) (NP (JJ human) (NN MSUD)))) (VP (VBD was) (ADVP-TMP (RB previously)) (VP (VBN created) (NP-1 (-NONE- *)) (PP-MNR (IN by) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG disrupting) (NP (DT the) (JJ mitochondrial) (NN BCAT) (NN gene))))) (PRN (-LRB- [) (NP (CD 20)) (-RRB- ])))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN BCKDH) (NN activity)) (PP-LOC (IN in) (NP (NP (DT the) (NML (NN liver) (CC and) (NN muscle))) (PP (IN of) (NP (DT this) (NN mouse)))))) (VP (VBD was) (ADJP-PRD (JJ normal)) (SBAR-ADV (RB even) (IN though) (S (NP-SBJ (DT the) (NN blood) (NN BCAA) (NNS levels)) (VP (VBD were) (ADJP-PRD (RB markedly) (JJ elevated)))))) (. .)) )
( (S (SBAR-ADV (IN While) (S (NP-SBJ (DT this)) (VP (VBZ is) (NP-PRD (DT an) (JJ interesting) (NN model))))) (, ,) (NP-SBJ (PRP it)) (VP (VBZ is) (RB not) (NP-PRD (NP (DT a) (JJ true) (NN model)) (PP (IN of) (NP (NN MSUD)))) (SBAR-PRP (IN because) (S (S (NP-SBJ (DT the) (NN mutation)) (VP (VBZ is) (RB not) (PP-PRD (IN in) (NP (NN BCKDH))))) (CC and) (S (NP-SBJ (NP (DT the) (NNS levels)) (PP (IN of) (NP (NN BCKDH)))) (VP (VBP are) (ADJP-PRD (JJ normal))))))) (. .)) )
( (S (ADVP (RB Furthermore)) (, ,) (NP-SBJ-1 (NP (DT no) (NN case)) (PP (IN of) (NP (NN MSUD)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (S-ADV (NP-SBJ (-NONE- *PRO*)) (VP (VBG attributing) (NP (DT this) (NN disease)) (PP (IN to) (NP (NN BCAT) (NN deficiency)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (NP (DT this) (NN mouse) (NN model))))) (, ,) (NP-SBJ-1 (NP (DT a) (NN cow) (NN model)) (PP (IN of) (NP (NN MSUD)))) (VP (VBZ has) (ADVP (RB also)) (VP (VBN been) (ADVP-TMP (RB previously)) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (NP (CD 17)) (PP (SYM -) (NP (CD 19)))) (-RRB- ]))))) (. .)) )
( (S (ADVP (RB However)) (, ,) (PP-PRP (PP (IN due) (IN to) (NP (NP (JJ practical) (NNS constraints)) (VP (VBN imposed) (NP (-NONE- *)) (PP (IN by) (NP-LGS (JJ such) (DT a) (JJ large) (NN animal) (NN model)))))) (CC and) (PP (IN due) (IN to) (NP (NP (DT the) (NN observation)) (PP (IN of) (NP (NP (NNS differences)) (PP (IN between) (NP (NP (DT the) (NN MSUD) (NN cow) (NN model)) (CC and) (NP (NN MSUD) (NNS humans)))))))) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))) (, ,) (NP-SBJ (DT this) (NN model)) (VP (VBZ is) (ADVP (RB also)) (PP-PRD (IN of) (NP (JJ limited) (NN utility)))) (. .)) )
( (S (PP (IN In) (NP (NN contrast))) (, ,) (NP-SBJ (NP (DT the) (JJ murine) (NNS models)) (VP (VBN described) (NP (-NONE- *)) (PP (IN in) (NP (DT this) (NN report))))) (VP (VBP are) (ADJP-PRD (RBR more) (JJ valid) (CC and) (JJ appropriate) (PP (IN for) (NP (VBG modeling) (JJ human) (NN MSUD))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (ADJP (RBS most) (JJ significant)) (NN opportunity)) (VP (VBN presented) (NP (-NONE- *)) (PP (IN by) (NP-LGS (DT the) (NN MSUD) (NN mouse) (NNS models))))) (VP (VBZ is) (S-PRD (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB test) (NP (NP (JJ novel) (NNS treatments)) (PP (JJ such) (IN as) (NP (ADJP (NP (NP (NN gene) (PRN (-LRB- [) (NP (NP (CD 38)) (PP (SYM -) (NP (CD 41)))) (-RRB- ]))) (CC and) (NP (NN cell))) (VBN based)) (NNS therapies) (PRN (-LRB- -LRB-) (NP (ADVP (FW e.g.)) (, ,) (NP (NNS hepatocytes) (PRN (-LRB- [) (NP (CD 42) (, ,) (CD 43)) (-RRB- ]))) (CC or) (NP (JJ embryonic) (NN stem) (NNS cells) (PRN (-LRB- [) (NP (CD 44)) (-RRB- ])))) (-RRB- -RRB-))))))))) (. .)) )
( (S (S-ADV (NP-SBJ (-NONE- *PRO*)) (ADJP-PRD (JJ Relevant) (PP (IN to) (NP (NN gene) (NN therapy))))) (, ,) (NP-SBJ (NP (JJ recent) (NNS problems)) (PP (IN with) (NP (NN gene) (NN therapy))) (PP-LOC (IN in) (NP (NNS humans)))) (VP (VBP highlight) (NP (NP (DT the) (NML (NML (NN importance)) (CC and) (NML (JJ critical) (NN need)))) (PP (IN of) (NP (NP (NN animal) (NNS models)) (PP (IN of) (NP (JJ genetic) (NNS diseases))))) (PP (IN for) (NP (JJ preclinical) (NNS studies))))) (. .)) )
( (S (NP-SBJ (NP (DT The) (NN testing)) (PP (IN of) (NP (ADJP (NP (NN gene) (CC and) (NN cell)) (VBN based)) (NNS therapies))) (PP (IN on) (NP (JJ appropriate) (NN animal) (NN model) (NNS systems)))) (VP (VBZ provides) (NP (NP (DT a) (JJ preliminary) (NN method)) (PP (IN of) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG establishing) (NP (CONJP (RB not) (RB only)) (NP (DT the) (NN efficacy)) (, ,) (CONJP (CC but) (RB also)) (NP (NML (ADJP (JJ short) (HYPH -) (CC and) (JJ long)) (HYPH -) (NN term)) (NN safety)))))))) (. .)) )
( (S (NP-SBJ-1 (NP (NN Success)) (PP (IN with) (NP (NN animal) (NNS studies)))) (VP (VP (VBZ is) (VP (VBN expected) (S (NP-SBJ-1 (-NONE- *)) (VP (TO to) (VP (VB advance) (NP (JJ such) (JJ therapeutic) (NNS approaches))))))) (CC and) (VP (MD could) (VP (VB pave) (NP (DT the) (NN way)) (PP (IN for) (NP (NP (NNS studies)) (PP-LOC (IN in) (NP (NNS humans)))))))) (. .)) )
( (S (PP (IN In) (NP (NP (NN addition)) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG testing) (NP (JJ various) (NNS treatments))))))) (, ,) (NP-SBJ (DT these) (NNS models)) (VP (MD should) (ADVP (RB also)) (VP (VB be) (ADJP-PRD (RB very) (JJ useful) (PP (IN for) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG investigating) (NP (NP (DT the) (VBG underlying) (JJ pathophysiologic) (NNS consequences)) (PP (IN of) (NP (DT the) (NN disease)))))))))) (. .)) )
( (S (NP-SBJ (JJ Such) (NNS studies)) (VP (VP (VBP are) (ADJP-PRD (ADJP (RB very) (JJ difficult)) (HYPH /) (ADJP (JJ impossible)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ (-NONE- *)) (VP (TO to) (VP (VB do) (NP-1 (-NONE- *T*)) (PP-LOC (IN in) (NP (JJ human) (NNS patients))) (PP-PRP (IN for) (NP (JJ obvious) (JJ ethical) (NNS reasons))))))))) (, ,) (CC and) (VP (ADVP-TMP (RB often)) (MD must) (VP (VB rely) (PP (IN on) (NP (NN autopsy) (NN tissue)))))) (. .)) )
( (S (ADVP (RB Additionally)) (, ,) (NP-SBJ (DT the) (JJ intermediate) (NN MSUD) (NN model)) (VP (MD may) (ADVP (RB also)) (VP (VB be) (ADJP-PRD (JJ useful) (PP (IN for) (NP (NP (NNS studies)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB test) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN thiamin))))))))))))) (. .)) )
( (S (NP-SBJ-1 (NP (DT A) (ADJP (NN thiamin) (HYPH -) (JJ responsive)) (NN form)) (PP (IN of) (NP (NN MSUD)))) (VP (VBZ has) (VP (VBN been) (VP (VBN described) (NP-1 (-NONE- *)) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))))) (. .)) )
( (S (S (NP-SBJ (NP (DT The) (NN phenotype)) (PP (IN of) (NP (DT these) (NNS patients)))) (VP (VBZ is) (ADJP-PRD (JJ heterogeneous)))) (CC and) (S (NP-SBJ (NP (NN treatment)) (PP (IN with) (NP (NP (DT a) (JJ wide) (NN range)) (PP (IN of) (NP (NN thiamin) (NNS doses)))))) (VP (VBZ has) (VP (VBN produced) (NP (JJ limited) (NN success)) (PRN (-LRB- [) (NP (CD 1)) (-RRB- ]))))) (. .)) )
( (S (NP-SBJ (NP (JJ Recent) (NML (NN cell) (NN culture)) (NNS studies)) (PP (IN with) (NP (NN MSUD) (NNS cells)))) (VP (VBP have) (VP (VBN suggested) (SBAR (IN that) (S (NP-SBJ (DT the) (ADJP (NN thiamin) (HYPH -) (JJ responsive)) (NN phenotype)) (VP (VBZ is) (ADJP-PRD (JJ dependent) (PP (IN upon) (NP (NP (DT the) (NN presence)) (PP (IN of) (NP (QP (RB at) (RBS least) (CD one)) (ADJP (NN E2) (VBG expressing)) (NN allele))))))))) (PRN (-LRB- [) (NP (CD 45) (, ,) (CD 46)) (-RRB- ])))) (. .)) )
( (S (PP (IN In) (NP (NP (NN light)) (PP (IN of) (NP (DT these) (JJR newer) (NNS findings))))) (, ,) (NP-SBJ (PRP$ our) (JJ intermediate) (NN MSUD) (NN mouse)) (VP (VBZ provides) (NP (NP (DT a) (NN model)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *T*)) (VP (TO to) (VP (VB test) (NP (NP (DT the) (NN effect)) (PP (IN of) (NP (NN thiamin)))) (PP (IN with) (NP (NP (NN respect)) (PP (IN to) (NP (NP (NN BCKDH) (NN activity)) (CC and) (NP (NN blood) (NML (NN amino) (NN acid)) (NNS levels)))))) (PP (IN at) (NP (NP (DT the) (NN level)) (PP (IN of) (NP (DT the) (JJ whole) (NN animal))))))))))) (. .)) )
( (S (PP-PRP (IN Because) (IN of) (NP (NP (JJ recent) (NN interest)) (PP (IN in) (NP (NP (JJ structural) (NN analysis)) (PP (IN of) (NP (NN multienzyme) (NNS complexes)))))) (PRN (-LRB- [) (NP (CD 35) (, ,) (CD 36) (, ,) (CD 45) (, ,) (CD 46)) (-RRB- ]))) (, ,) (NP-SBJ (DT the) (JJ intermediate) (NN MSUD) (NN model)) (VP (MD may) (VP (VB provide) (NP (NP (DT a) (JJ valuable) (NN resource)) (PP (IN for) (NP (NP (NNS studies)) (PP (IN of) (NP (JJ structural) (NN biology)))))))) (. .)) )
( (S (ADVP (RB Lastly)) (, ,) (NP-SBJ (NP (DT the) (NML (NN information) (CC and) (NN knowledge))) (VP (VBN gained) (NP (-NONE- *)) (PP (IN from) (NP (NP (NNS studies)) (PP (IN with) (NP (NP (DT the) (NN MSUD) (NNS models)) (VP (VBN described) (NP (-NONE- *)) (ADVP (RB here))))))))) (VP (MD will) (ADVP (RB also)) (VP (VB be) (ADJP-PRD (JJ applicable) (CC and) (JJ transferable) (PP (IN to) (NP (JJ other) (JJ mitochondrial) (NNS disorders)))) (PP-PRP (IN due) (IN to) (NP (NP (NNS defects)) (PP-LOC (IN in) (NP (JJ multisubunit) (NNS enzymes))))))) (. .)) )
( (HEADING (NP (NN Conclusion))) )
( (S (PP (IN In) (NP (NN summary))) (, ,) (NP-SBJ (DT this) (NN report)) (VP (VBZ describes) (NP (NP (DT the) (NML (NN development) (CC and) (NN characterization))) (PP (IN of) (NP (NP (ADJP (RB genetically) (VBN engineered)) (NN mouse) (NNS models)) (PP (IN of) (NP (ADJP (JJ classic) (CONJP (RB as) (RB well) (IN as)) (JJ intermediate)) (NN MSUD))))))) (. .)) )
( (S (NP-SBJ (DT These) (NNS animals)) (VP (VBP provide) (NP (NP (JJ useful) (NNS models)) (SBAR (WHNP-1 (-NONE- *0*)) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (ADVP (RB further)) (VP (VB characterize) (NP (NP (DT the) (NN pathogenesis)) (PP (IN of) (NP (NN MSUD))))))))) (, ,) (CONJP (RB as) (RB well) (IN as)) (NP (NP (NNS models)) (SBAR (WHNP-2 (-NONE- *0*)) (S (NP-SBJ-2 (-NONE- *T*)) (VP (TO to) (VP (VB test) (NP (NP (JJ novel) (JJ therapeutic) (NNS strategies)) (, ,) (PP (JJ such) (IN as) (NP (UCP (NN gene) (CC and) (JJ cellular)) (NNS therapies)))) (, ,) (S-PRP (NP-SBJ (-NONE- *PRO*)) (VP (TO to) (VP (VB treat) (NP (DT this) (VBG devastating) (JJ metabolic) (NN disease))))))))))) (. .)) )
( (HEADING (NP (NNS Abbreviations))) )
( (S (NP-SBJ (NP (DT The) (NNS abbreviations)) (VP (VBN used) (NP (-NONE- *)))) (VP (VBP are) (: :) (NP-PRD (NP (NP (NN MSUD)) (, ,) (NP (NML (JJ Maple) (NN Syrup)) (NN Urine) (NN Disease))) (: ;) (NP (NP (NN BCKDH)) (, ,) (NP (NML (VBN branched) (NN chain)) (NN ketoacid) (NN dehydrogenase))) (: ;) (NP (NP (NN BCAA)) (, ,) (NP (NML (VBN branched) (NN chain)) (NN amino) (NNS acids))) (: ;) (NP (NP (NN ENU)) (, ,) (NP (NML (NN N) (HYPH -) (NN ethyl)) (HYPH -) (NN N) (HYPH -) (NN nitrosourea))) (: ;) (NP (NP (NN BCAT)) (, ,) (NP (NML (VBN branched) (NN chain)) (NN aminotransferase))) (: ;) (NP (NP (NN ES) (NN cell)) (, ,) (NP (JJ embryonic) (NN stem) (NN cell))) (: ;) (NP (NP (NN TRE)) (, ,) (NP (NN tetracycline) (JJ responsive) (NN element))) (: ;) (NP (NP (NN MEF)) (, ,) (NP (NN mouse) (JJ embryonic) (NN fibroblast))))) (. .)) )
( (HEADING (NP (VBG Competing) (NNS interests))) )
( (S (NP-SBJ (DT The) (NN author) (-LRB- -LRB-) (AFX s)) (-RRB- -RRB-) (VP (VBP declare) (SBAR (IN that) (S (NP-SBJ (PRP they)) (VP (VBP have) (NP (DT no) (VBG competing) (NNS interests)))))) (. .)) )
( (HEADING (NP (NP (NNS Authors) (POS ')) (NNS contributions))) )
( (S (NP-SBJ (NNP GEH)) (VP (VP (VBD designed) (CC and) (VBD produced) (NP (DT the) (NN mouse) (NNS models))) (, ,) (VP (VBN coordinated) (NP (NNS experiments))) (, ,) (VP (VBN interpreted) (NP (NNS data))) (, ,) (CC and) (VP (VBN helped) (VP (VB draft) (NP (DT the) (NN manuscript))))) (. .)) )
( (S (NP-SBJ (NNP KS)) (VP (VBD conducted) (NP (NP (JJ much)) (PP (IN of) (NP (NP (DT the) (NN characterization)) (PP (IN of) (NP (DT the) (JJ intermediate) (NN MSUD) (NN model))))))) (. .)) )
( (S (NP-SBJ (NNP CF)) (VP (VBD assisted) (PP (IN with) (NP (NP (NP (NN production)) (PP (IN of) (NP (DT the) (NN mouse) (NNS models)))) (, ,) (NP (NNS data) (NN collection)) (, ,) (NP (NN analysis)) (, ,) (CC and) (NP (NN interpretation))))) (. .)) )
( (S (NP-SBJ (NNP SW)) (VP (VBD directed) (NP (DT the) (NN immunohistochemistry) (NNS experiments))) (. .)) )
( (S (NP-SBJ (NNP HSP)) (VP (VP (VBD conceived) (PP (IN of) (NP (DT the) (NN knockout) (NN model)))) (, ,) (VP (VBN interpreted) (NP (NNS data))) (CC and) (VP (VBD drafted) (NP (DT the) (NN manuscript)))) (. .)) )
( (S (NP-SBJ (DT All) (NNS authors)) (VP (VP (VBD contributed) (PP (IN to) (S-NOM (NP-SBJ (-NONE- *PRO*)) (VP (VBG composing) (CC and) (VBG editing) (NP (DT the) (NN manuscript)))))) (CC and) (VP (VBP have) (VP (VBN read) (CC and) (VBN approved) (NP (DT the) (JJ final) (NN version))))) (. .)) )
( (HEADING (NP (NN Pre-publication) (NN history))) )
( (S (NP-SBJ-1 (NP (DT The) (JJ pre-publication) (NN history)) (PP (IN for) (NP (DT this) (NN paper)))) (VP (MD can) (VP (VB be) (VP (VBN accessed) (NP-1 (-NONE- *)) (ADVP (RB here))))) (: :)) )
( (HEADING (NP (NNS Acknowledgements))) )
( (S (NP-SBJ-1 (DT The) (NNS authors)) (VP (MD would) (VP (VB like) (S (NP-SBJ-1 (-NONE- *PRO*)) (VP (TO to) (VP (VP (VB thank) (NP=2 (NP (NNP Frank) (NNP Kist)) (, ,) (NP (NNP Jodi) (NNP Dagget)) (, ,) (NP (NNP Edward) (NNP Mallick)) (, ,) (NP (NNP Brian) (NNP Sloat)) (, ,) (CC and) (NP (NNP Judith) (NNP Rodda))) (PP-PRP=3 (IN for) (NP (NN expert) (JJ technical) (NN assistance)))) (, ,) (CC and) (VP (NP=2 (NNP Dr.) (NNP Susan) (NNP Hutson)) (PP-PRP=3 (IN for) (NP (NP (DT the) (NN gift)) (PP (IN of) (NP (NN E2) (NN antiserum))))))))))) (. .)) )
( (S (NP-SBJ-1 (DT This) (NN work)) (VP (VBD was) (VP (VBN supported) (NP-1 (-NONE- *)) (PP (IN by) (NP-LGS (NP (NML (NML (NNP National) (NNPS Institutes)) (PP (IN of) (NP (NNP Health)))) (NNPS Grants) (NML (NN DK51960) (, ,) (NN DK57386) (, ,) (NN DK57956) (, ,) (NN AA10422))) (, ,) (NP (DT the) (NML (NNP Scott) (NNP C.) (NNP Foster)) (NML (NNP Metabolic) (NNP Disease)) (NNP Fund)) (, ,) (CC and) (NP (DT the) (NNP MSUD) (NML (NNP Family) (NNP Support)) (NNP Group)))))) (. .)) )
